rfhg_188682.1

Basic information about the TSS

---

TSS ID: rfhg_188682.1 Species: human Chr: chr17		Start: 4940976 End: 4941000 Strand: +
Source datasets	FANTOM5|DRA000914
Protocol	CAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D2903605,EH38E1842787)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000572554.1:0 AY960626:0 AL050060:0 GeneID: 26001 HGNC/MGI_ID: HGNC:24544 UniProt_ID: Nearer transcript ids and distances: CR457340:-66 KJ893506:-67 KJ898582:-67 BC010139:-240 BC013222:-295 ENST00000575400.5:-317 ENST00000570492.5:-318 AY203930:-342 AL834284:-364 ENST00000576229.5:-489 view more...

Gene_name: ring finger protein 167 Gene_symbol: RNF167 Gene_synonyms: DKFZP566H073 Gene_source: HGNC:24544

TATA-Box annotation

---

Distance to TSS:	720
Nearest PromoterID:	NM_001320363
Entrez ID:	26001
Nearest Unigene:	Hs.7158
Nearest Refseq:	NM_015528
Nearest Ensembl:	ENSG00000108523
Gene Name:	ring finger protein 167
Gene Alias:	5730408C10Rik|LP2254|RING105
Gene Type:	protein-coding
CpG%:	0.125000
GC%:	0.680000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RNF167 p2@RNF167 p3@RNF167 p4@RNF167 p5@RNF167 p6@RNF167 p7@RNF167 p8@RNF167 p9@RNF167 p10@RNF167
Sample		p1@RNF167	p2@RNF167	p3@RNF167	p4@RNF167	p5@RNF167	p6@RNF167	p7@RNF167	p8@RNF167	p9@RNF167	p10@RNF167
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	48.31	14.61	16.36	13.25	11.49	15.39	5.65	2.73	5.26	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	48.76	15.58	21.04	15.17	8.30	16.99	6.88	4.05	7.08	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	45.14	12.73	20.83	14.85	10.03	15.82	4.63	4.63	4.63	2.12
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	44.70	12.27	17.67	11.64	10.81	17.05	8.11	3.53	5.61	2.29
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.92	14.40	18.45	12.82	8.77	17.32	6.75	4.95	5.62	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	43.41	11.63	18.41	13.57	7.75	17.25	6.40	3.10	3.68	1.16
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	63.84	15.03	33.34	27.67	7.63	18.74	11.98	10.68	5.45	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	52.80	16.71	23.01	23.74	7.75	25.19	7.02	10.42	6.06	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	56.21	14.96	25.65	23.08	10.26	21.59	9.62	7.05	3.85	2.14
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	74.77	20.87	31.30	9.85	19.71	30.72	5.80	2.90	6.38	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	73.97	16.17	35.17	8.49	17.38	31.13	7.28	6.06	4.45	0.81
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	73.18	17.48	41.87	6.10	15.04	24.80	6.10	2.85	5.29	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	53.52	4.84	9.67	3.71	0.97	1.77	0.97	1.29	0.81	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	56.23	4.81	9.02	5.71	0.60	2.10	0.60	0.90	0.75	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	47.20	4.39	9.22	5.27	0.22	1.10	0.66	0.88	0.88	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	58.09	3.27	10.31	4.53	0.50	1.51	0.75	0.50	0.75	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	55.04	2.62	8.74	2.62	0.66	1.09	1.53	0.87	0.87	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	64.54	1.27	11.81	2.11	0.00	1.27	0.84	0.42	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	59.71	2.13	9.06	1.60	1.07	2.13	0.53	0.53	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	46.79	6.17	8.88	5.12	0.45	3.16	0.75	0.75	0.90	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	49.45	4.01	5.48	4.01	0.40	2.14	0.40	1.34	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	52.30	3.45	6.90	5.01	0.52	0.86	0.86	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	46.66	4.01	10.86	3.75	0.26	1.68	1.55	0.52	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	47.56	3.40	7.04	3.40	0.49	1.94	0.49	1.21	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	53.40	2.32	10.32	3.61	0.52	1.29	0.00	1.29	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.69	2.85	9.18	4.43	0.32	3.80	0.63	0.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	63.19	2.75	10.99	3.85	1.10	4.40	1.65	0.55	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	51.16	6.37	5.42	4.24	0.00	2.36	0.94	2.36	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	51.69	4.68	8.40	3.39	0.32	2.75	0.97	1.78	0.16	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.06	6.33	8.87	3.26	0.36	1.81	0.90	1.27	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	43.54	3.35	7.54	3.56	0.84	0.84	1.26	0.21	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.21	4.49	9.96	2.54	0.39	1.56	0.39	1.37	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	47.48	5.06	8.44	4.85	0.63	2.74	0.84	1.69	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.53	4.78	10.23	4.45	0.33	1.81	1.32	0.82	1.32	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	44.50	5.05	8.60	2.99	0.56	1.31	0.56	0.56	0.93	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	48.86	4.22	7.28	3.45	0.96	1.92	0.38	2.11	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	41.69	6.13	8.99	2.04	0.41	1.02	0.61	1.02	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	43.12	4.84	7.66	1.81	0.40	1.01	0.40	1.01	0.40	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	46.46	6.48	7.56	3.51	0.27	1.62	0.54	0.81	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	43.93	4.08	6.96	1.44	0.24	1.68	1.68	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	43.76	4.00	8.00	2.12	0.71	1.88	0.94	1.65	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	44.80	3.66	10.54	3.66	0.59	1.76	0.88	1.17	0.15	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.85	7.38	7.59	2.95	1.27	1.90	1.90	1.05	0.21	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	50.87	3.67	7.52	3.85	0.35	1.75	0.87	0.87	0.35	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	37.75	6.22	7.63	2.81	0.80	2.81	1.41	0.20	0.80	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	38.85	5.35	6.75	1.86	1.16	0.70	0.70	0.70	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	41.02	4.08	8.40	1.44	0.48	3.12	1.20	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	45.60	8.05	8.05	2.09	0.89	1.49	0.60	1.19	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	45.24	4.07	9.57	2.39	0.72	2.15	0.96	0.24	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	43.88	7.68	7.68	2.22	0.40	3.03	1.01	0.81	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	48.37	5.53	7.38	2.05	1.64	2.46	1.02	0.41	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	49.59	8.67	8.01	1.33	1.11	2.45	0.44	0.44	1.11	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	27.98	27.98	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	40.10	3.90	12.42	2.48	1.06	1.06	0.71	1.42	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	40.43	4.64	7.29	2.32	0.66	0.66	0.66	0.66	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	44.46	5.03	8.39	5.03	0.00	1.68	0.84	3.36	0.00	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	55.11	5.51	5.05	4.13	0.00	1.84	0.46	0.46	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	45.70	5.19	4.54	1.62	1.62	2.92	1.30	0.00	1.62	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	39.50	3.85	6.42	0.96	0.64	0.96	1.28	1.28	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	53.75	6.60	10.06	4.71	0.00	1.89	0.31	0.63	1.57	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	35.96	4.23	2.82	0.71	0.00	3.53	0.71	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	42.62	4.49	2.80	1.12	2.24	1.68	0.00	0.00	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	41.40	3.18	15.13	5.57	3.18	3.18	0.80	1.59	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	51.30	5.10	7.14	2.38	0.34	3.06	0.34	1.70	1.70	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	51.66	5.85	7.15	1.30	0.97	1.62	0.97	0.00	1.95	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	41.18	2.13	6.03	0.71	1.77	1.06	0.71	1.06	1.06	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	7.90	15.79	0.00	0.00	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	48.26	4.39	8.78	1.95	0.00	0.98	0.00	2.44	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	37.69	2.48	4.96	1.49	0.50	1.98	1.49	0.50	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	45.97	3.28	6.10	1.88	0.94	0.94	0.00	0.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.76	2.32	8.61	1.66	0.99	2.32	0.33	0.33	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.57	2.17	7.11	1.24	0.31	1.55	0.31	1.55	0.62	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.44	1.53	4.89	2.75	0.00	1.22	0.00	0.00	1.22	0.00
Adipocyte - breast, donor1	11376-118A8	56.38	3.80	5.07	1.58	0.63	2.22	0.48	0.95	1.74	0.32
Adipocyte - breast, donor2	11327-117E4	47.49	4.97	3.53	1.44	0.80	2.25	1.44	0.48	0.48	0.48
Adipocyte - omental, donor1	11473-119C6	65.39	4.33	6.23	3.05	1.27	2.93	1.27	1.78	0.89	0.89
Adipocyte - omental, donor2	11474-119C7	53.07	2.99	4.48	2.24	0.75	1.49	0.75	0.00	0.75	1.49
Adipocyte - omental, donor3	11475-119C8	74.69	4.69	4.69	2.01	0.33	1.67	1.34	0.33	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	84.21	6.38	7.02	1.91	0.64	3.19	0.00	0.00	2.55	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	29.69	2.20	0.00	1.10	0.00	0.00	0.00	1.10	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	49.68	4.06	2.26	3.16	0.90	2.71	0.45	0.45	1.35	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	63.95	7.99	3.65	3.82	1.39	3.30	1.22	0.35	0.00	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	29.53	7.04	1.96	1.96	0.39	2.15	0.59	0.78	0.20	1.56
Adipocyte differentiation, day04, donor2	13022-139D7	16.21	4.89	2.83	1.80	1.03	0.51	0.77	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	26.20	6.97	1.67	1.39	1.95	1.67	1.39	0.00	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	5.88	0.00	4.70	0.59	2.35	0.00	2.35	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	45.85	5.39	3.14	4.42	0.88	2.33	1.45	0.72	0.16	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	32.92	5.49	0.97	2.26	1.29	2.90	0.65	0.65	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	29.33	4.27	2.13	3.20	0.53	2.13	0.53	0.53	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	37.84	4.45	4.45	2.78	0.00	0.00	0.56	1.11	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	37.01	3.33	3.74	5.82	0.83	2.91	3.33	0.42	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	33.15	7.28	2.26	2.01	1.00	3.27	0.50	0.25	0.50	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	32.72	5.89	2.62	1.31	0.65	2.62	1.31	1.31	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	30.45	3.96	2.74	2.13	0.30	2.13	0.61	1.22	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	50.61	7.73	20.99	5.08	0.88	3.98	1.99	1.77	5.97	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	77.10	11.12	50.20	8.96	1.43	1.08	0.72	1.43	14.34	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	35.94	4.79	15.57	4.79	0.00	3.59	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	35.44	6.66	7.74	9.89	0.36	3.60	1.26	1.44	1.98	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	61.92	6.69	6.69	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.72	6.37	7.40	7.19	0.41	1.64	1.23	0.41	1.23	0.82
Anulus Pulposus Cell, donor1	11248-116E6	70.26	3.89	5.15	2.40	0.57	1.37	0.69	0.80	0.34	0.46
Anulus Pulposus Cell, donor2	11463-119B5	60.25	1.96	4.65	1.96	0.49	0.98	0.73	0.49	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	34.60	3.59	3.15	3.15	1.35	0.90	0.90	0.45	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	33.86	2.17	10.42	3.47	0.00	2.17	0.00	0.87	1.30	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	2.14	6.42	0.00	0.00	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	32.88	2.99	5.68	2.39	0.30	0.90	0.60	0.30	2.69	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	34.15	2.53	11.38	1.26	1.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	31.02	1.32	5.94	3.30	0.66	1.32	1.32	1.98	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	35.41	2.27	7.15	0.65	0.97	0.97	0.65	0.32	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.50	1.46	6.31	0.49	0.97	1.94	0.49	0.49	0.97	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	27.91	3.56	5.94	1.78	0.00	1.19	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	22.97	2.26	6.78	2.26	0.38	1.13	0.00	0.38	1.51	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	33.38	1.45	6.53	2.90	0.00	0.00	0.00	0.00	3.63	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	31.34	1.25	6.27	2.51	0.00	2.51	0.00	1.25	3.76	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	34.43	1.81	6.75	2.31	0.66	1.81	0.99	0.99	2.31	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	4.09	8.19	4.09	0.00	2.73	0.00	1.36	4.09	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.63	2.41	4.67	1.36	0.60	1.51	0.45	0.15	1.51	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	30.54	1.61	5.89	3.21	0.00	0.00	0.54	1.07	2.68	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.91	4.53	4.16	3.21	0.38	1.89	0.57	0.76	1.13	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	32.88	1.60	7.22	1.60	0.53	0.80	0.27	0.80	1.60	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	32.19	2.93	5.85	0.98	0.98	2.93	0.00	0.98	2.93	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.22	2.32	5.97	2.16	1.00	1.00	1.16	0.83	1.82	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	31.22	1.20	6.00	0.00	0.00	1.20	1.20	1.20	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.30	2.74	4.46	1.54	0.34	1.03	0.34	0.17	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	4.19	0.00	4.19	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	37.38	0.97	9.22	1.94	0.97	0.49	0.49	0.49	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	29.98	2.66	2.66	1.52	0.38	0.38	0.38	0.38	1.90	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	1.21	4.85	0.00	0.00	1.21	2.42	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	41.61	1.14	10.26	0.00	0.00	0.57	0.57	1.14	3.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	29.71	2.99	4.06	2.14	0.00	1.71	0.43	0.00	2.78	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	29.94	2.58	5.42	1.55	0.00	1.03	0.52	0.52	2.32	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.03	2.82	8.91	0.47	0.94	1.88	1.41	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.55	2.25	9.00	2.25	0.32	3.22	0.32	0.00	1.61	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	29.96	0.00	12.13	1.43	0.71	1.43	0.71	0.00	2.14	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	29.25	5.85	7.02	2.34	0.00	1.75	1.75	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.11	3.91	3.91	1.81	0.60	1.81	0.30	0.60	2.11	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	27.32	2.38	9.50	2.38	0.00	2.38	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.56	3.05	8.14	0.51	0.00	1.02	0.51	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	32.35	3.31	5.35	2.29	0.00	1.02	0.51	0.51	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	38.76	2.54	4.45	3.18	0.00	0.00	1.27	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	37.54	3.02	6.04	1.73	0.43	2.16	0.43	0.43	0.86	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.69	2.96	5.50	1.91	0.21	1.48	0.42	0.64	1.48	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	25.23	1.45	6.09	1.45	0.29	0.87	0.00	0.87	0.58	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	38.73	1.89	6.61	3.78	0.00	1.89	4.72	0.00	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	24.07	2.54	3.39	2.37	0.34	0.51	0.17	1.19	1.53	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	25.48	0.00	9.27	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	31.69	2.11	6.34	2.11	0.00	2.11	0.00	2.11	4.23	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	28.09	3.00	4.29	2.36	0.64	1.29	0.86	0.43	1.50	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	32.49	0.60	3.61	0.60	0.60	0.00	0.60	0.00	3.01	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.06	3.64	6.56	0.73	0.00	1.46	0.00	2.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	32.64	3.68	5.52	2.99	0.69	0.69	0.46	0.23	2.07	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	25.50	0.00	7.65	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.76	2.29	6.10	2.29	0.25	1.27	0.25	0.25	1.78	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	29.52	1.45	7.02	3.10	0.62	1.03	0.41	0.00	1.45	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	32.44	2.45	6.12	1.84	0.00	0.92	0.92	0.31	1.53	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	36.33	1.91	7.17	2.39	0.00	0.96	0.00	0.00	0.96	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.28	1.55	3.55	2.22	0.22	0.22	0.44	0.22	2.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	35.09	0.00	4.58	1.53	0.00	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.82	2.77	6.65	1.11	1.11	2.22	1.11	0.00	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	28.86	3.44	6.36	2.12	0.79	1.59	0.79	0.26	1.59	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.62	3.63	6.91	1.82	0.36	2.18	0.73	0.00	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	67.18	10.32	6.14	8.47	0.74	3.32	2.21	1.72	0.74	0.61
Astrocyte - cerebellum, donor2	11580-120F5	60.59	6.68	5.48	6.50	0.34	2.74	1.37	1.54	1.20	0.17
Astrocyte - cerebellum, donor3	11661-122F5	51.81	6.50	5.24	2.94	0.21	3.36	2.10	1.47	0.00	1.26
Astrocyte - cerebral cortex, donor1	11235-116D2	38.34	7.32	2.79	2.79	0.35	1.74	3.14	1.39	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	49.18	4.04	7.44	4.53	0.16	2.91	0.97	0.49	0.97	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	34.90	7.16	5.37	4.33	0.60	3.43	1.49	2.09	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	26.38	15.25	1.72	6.31	15.02	2.52	0.92	1.83	0.11	5.73
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	30.44	15.66	1.00	6.39	13.78	3.63	1.25	1.50	0.38	5.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.73	13.31	2.16	6.15	13.77	2.96	1.82	1.93	0.23	5.12
Basophils, donor1	12241-129G9	10.20	14.12	0.52	2.62	14.65	5.49	2.35	1.05	0.00	3.66
Basophils, donor2	12242-129H1	9.02	15.87	1.08	2.16	31.39	4.69	2.16	1.08	0.00	3.97
Basophils, donor3	12243-129H2	9.85	18.96	0.44	2.79	11.32	2.65	0.88	0.44	0.00	3.67
Bronchial Epithelial Cell, donor1	11511-119G8	47.00	6.25	21.13	6.04	0.22	1.29	0.86	0.86	4.10	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	64.46	7.31	45.72	9.60	0.46	1.37	2.29	0.00	7.31	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	86.08	7.17	28.69	0.00	0.00	0.00	0.00	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	56.49	4.39	28.87	2.51	1.26	1.88	1.26	0.63	6.90	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	49.49	7.28	23.91	3.33	1.04	2.70	1.04	1.87	4.57	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	50.43	8.75	16.81	3.45	0.00	1.15	0.46	0.46	0.92	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	35.63	4.14	18.89	6.30	0.18	1.62	0.36	1.62	1.08	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.32	22.05	1.85	6.39	32.57	4.02	1.96	1.44	0.10	5.46
Burkitt's lymphoma cell line:RAJI	10476-106I8	16.54	15.60	2.79	1.63	19.33	2.10	0.23	0.47	0.00	5.59
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	33.26	15.67	6.08	2.88	12.15	4.16	0.64	1.60	0.32	1.92
CD133+ stem cells - cord blood derived, pool1	12223-129E9	51.71	10.34	10.34	10.34	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	7.89	13.53	1.13	2.25	7.33	3.94	3.94	0.00	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	10.95	14.29	0.56	2.41	10.02	1.48	0.93	0.93	0.19	2.97
CD14+ Monocytes, donor3	11381-118B4	9.88	13.17	0.44	1.10	9.88	2.63	2.41	0.88	0.00	3.07
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	34.25	19.81	1.42	5.38	4.25	2.83	0.85	1.70	0.00	2.83
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	27.67	24.26	0.76	7.96	8.34	4.55	0.38	0.38	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.63	23.01	1.31	6.90	3.94	3.62	0.99	1.31	0.00	2.96
CD14+ monocytes - mock treated, donor1	11863-125A9	9.25	18.07	1.16	1.45	10.99	3.61	1.88	0.14	0.00	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	4.22	9.66	0.60	2.11	5.73	2.72	1.51	0.91	0.30	2.11
CD14+ monocytes - mock treated, donor3	11883-125D2	8.29	17.77	1.42	0.95	7.58	5.21	2.37	0.71	0.47	2.13
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.86	9.54	0.17	0.84	9.54	1.84	1.00	0.84	0.17	1.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.69	9.11	0.28	0.28	4.42	3.04	0.55	0.28	0.00	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	2.98	10.41	0.25	0.25	8.43	3.47	1.49	0.25	0.25	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.70	15.27	0.39	0.20	5.48	2.74	0.78	0.20	0.20	3.13
CD14+ monocytes - treated with BCG, donor2	11870-125B7	4.45	9.97	0.89	0.71	6.05	2.85	0.36	0.36	0.00	1.96
CD14+ monocytes - treated with BCG, donor3	11880-125C8	5.22	11.32	0.65	0.87	6.96	1.96	0.87	0.87	0.44	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.62	10.54	0.47	0.47	6.56	2.81	0.70	0.00	0.00	2.11
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.81	7.92	0.00	1.06	4.75	3.17	0.53	0.00	0.00	2.64
CD14+ monocytes - treated with Candida, donor3	11888-125D7	4.44	12.20	1.11	1.11	3.33	5.55	0.00	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	6.25	11.60	0.45	0.89	7.73	2.23	1.49	0.15	0.15	2.23
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	4.99	8.58	0.40	0.40	5.39	2.99	1.00	0.40	0.20	1.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	2.71	10.62	0.83	1.25	6.87	4.58	1.46	1.87	0.00	2.29
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.03	14.18	0.46	0.92	6.18	1.60	0.69	0.46	0.23	2.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.30	9.95	0.68	0.23	4.52	3.17	1.36	0.23	0.00	0.68
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	10.04	1.31	0.87	6.55	1.31	0.87	0.00	0.00	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	6.19	10.76	0.27	0.27	6.72	2.96	0.81	0.00	0.00	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	6.28	12.56	0.17	0.70	5.23	1.74	1.40	0.70	0.00	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	10.10	0.42	0.42	10.94	3.79	0.84	0.42	0.00	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	3.12	10.47	0.37	0.37	6.43	1.65	0.55	0.37	0.18	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	1.41	5.28	0.00	0.35	5.99	2.47	0.35	0.00	0.00	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	3.07	8.34	0.88	0.00	5.70	2.63	1.32	0.00	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.23	10.11	0.17	0.17	6.45	2.27	0.87	0.35	0.17	1.92
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.83	13.01	0.37	0.74	4.83	1.49	1.12	0.00	0.37	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	4.96	13.80	1.08	1.51	9.48	3.02	1.08	0.22	0.00	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	5.73	6.14	0.82	1.64	4.50	2.05	2.46	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	7.88	0.23	0.23	4.87	1.85	0.93	0.00	0.00	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.32	8.58	0.46	0.70	9.28	1.86	0.93	0.23	0.00	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	13.73	21.58	0.65	4.14	10.90	5.23	4.14	0.65	0.22	2.18
CD14+CD16+ Monocytes, donor2	11801-124D1	15.71	21.48	1.15	3.93	10.86	4.62	2.54	1.85	0.46	2.77
CD14+CD16+ Monocytes, donor3	11912-125G4	12.13	20.36	0.87	3.25	10.18	3.47	3.03	1.08	0.22	3.03
CD14+CD16- Monocytes, donor1	11788-124B6	30.05	23.36	1.09	6.70	6.38	5.76	2.80	3.58	0.31	4.52
CD14+CD16- Monocytes, donor2	11799-124C8	23.40	21.13	0.70	2.79	5.24	4.37	3.32	1.40	0.17	4.19
CD14+CD16- Monocytes, donor3	11910-125G2	16.95	27.43	0.89	6.02	6.69	6.47	2.23	1.56	0.22	4.01
CD14-CD16+ Monocytes, donor1	11790-124B8	15.82	19.14	0.26	1.28	18.12	2.55	1.79	0.00	0.26	3.32
CD14-CD16+ Monocytes, donor2	11800-124C9	15.37	22.62	1.76	3.29	21.96	7.90	1.98	0.88	0.66	3.51
CD14-CD16+ Monocytes, donor3	11911-125G3	12.42	18.32	1.05	1.89	19.37	5.05	1.26	1.26	0.42	5.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	36.58	2.03	10.16	8.13	2.03	6.10	6.10	0.00	10.16
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	33.22	0.68	13.56	6.10	7.46	6.10	8.14	0.68	8.81
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	32.10	0.00	7.25	16.57	11.39	2.07	6.21	0.00	10.36
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.40	28.78	0.53	10.66	12.26	8.53	3.73	1.60	1.07	5.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	8.04	42.89	0.00	10.19	12.33	8.58	1.61	8.04	0.00	5.36
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	11.23	37.20	0.00	11.23	9.83	7.02	4.21	3.51	1.40	5.62
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	30.59	0.00	13.33	7.84	10.98	4.71	3.92	0.78	7.84
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	44.82	2.64	7.91	5.27	11.86	2.64	6.59	0.00	7.91
CD19+ B Cells, donor1	11544-120B5	3.29	42.74	0.00	3.29	12.33	11.51	4.93	2.47	0.00	1.64
CD19+ B Cells, donor2	11624-122B4	3.63	33.37	0.00	3.63	11.61	5.08	1.45	0.73	0.00	4.35
CD19+ B Cells, donor3	11705-123B4	3.53	30.29	0.50	3.53	9.59	5.55	3.03	0.50	1.01	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	90.10	40.81	11.72	13.74	17.78	12.53	4.04	3.64	1.21	10.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	72.71	38.75	5.59	14.38	11.98	10.39	5.59	2.80	0.00	7.59
CD34+ Progenitors, donor1	11545-120B6	19.08	6.02	1.00	1.00	3.01	1.00	0.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	7.87	13.48	2.81	0.56	9.55	2.81	0.00	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	28.93	24.42	4.88	4.51	9.39	3.76	2.63	1.50	0.38	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	36.53	21.20	5.19	4.74	14.43	4.96	4.06	0.68	0.23	5.64
CD4+ T Cells, donor1	11225-116C1	5.36	22.85	0.71	1.07	28.56	5.71	3.21	1.43	0.36	5.71
CD4+ T Cells, donor2	11306-117C1	4.29	16.53	0.61	0.61	33.68	4.90	1.22	0.00	1.22	7.35
CD4+ T Cells, donor3	11382-118B5	7.01	24.09	1.83	0.91	34.16	6.71	2.44	0.61	0.30	3.66
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	14.04	34.46	3.57	1.28	69.17	5.62	3.57	1.02	1.02	14.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	19.76	30.10	2.47	6.06	68.95	5.39	3.14	1.57	1.12	17.07
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	12.65	28.46	1.72	2.01	77.04	6.04	2.01	2.30	1.15	16.96
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.79	29.87	0.00	3.32	30.34	17.07	3.79	2.37	0.95	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	6.32	40.73	0.70	5.62	30.20	9.83	7.73	2.81	0.70	9.83
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	3.30	42.85	3.30	0.00	32.96	26.37	16.48	3.30	0.00	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	26.16	22.54	5.20	2.89	87.14	7.95	2.46	0.58	1.73	17.05
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	36.77	25.76	10.17	1.53	88.29	5.76	2.03	1.02	3.73	13.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	30.15	19.51	5.32	3.22	71.25	5.64	2.74	0.64	0.81	12.57
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	5.38	36.31	0.90	4.93	45.73	4.48	1.79	0.45	0.00	9.86
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	2.80	24.81	3.14	3.14	50.66	6.29	2.80	4.54	1.05	9.43
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.92	29.04	1.76	5.28	47.52	9.68	3.52	0.44	0.44	12.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	21.08	18.13	8.43	2.11	72.52	7.17	3.79	2.11	2.11	11.81
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.91	15.17	2.70	0.62	63.16	3.53	1.45	0.21	1.87	11.43
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	15.37	19.71	4.01	1.00	76.18	4.01	2.00	0.00	2.00	8.02
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	9.52	48.95	0.82	3.81	26.65	12.51	10.06	1.36	0.27	10.33
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	11.25	60.03	0.54	4.29	30.55	12.86	4.82	1.61	1.07	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	16.14	48.42	1.79	3.59	35.86	12.55	8.97	1.79	0.00	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.89	23.55	8.34	2.78	110.70	7.60	2.41	2.23	2.04	18.91
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	27.29	27.73	5.42	2.82	102.24	7.15	2.82	0.65	2.60	13.65
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	26.69	32.78	7.57	2.10	156.77	8.20	2.10	1.68	3.15	19.12
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	9.10	26.80	1.52	2.53	34.89	10.11	4.55	2.53	2.53	6.07
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	9.53	29.03	2.17	3.03	33.79	5.63	3.90	2.60	1.30	5.63
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	10.90	35.74	4.79	2.61	57.09	13.95	2.18	1.31	0.44	14.82
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	11.88	43.55	1.98	8.41	55.92	17.32	4.45	1.98	0.49	16.33
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	36.00	3.69	0.92	59.08	14.77	2.77	2.77	0.00	12.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	39.08	2.79	4.19	54.44	12.56	6.98	1.40	1.40	12.56
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.29	47.35	1.66	7.75	39.32	14.40	5.54	1.11	0.83	10.25
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	12.51	54.23	2.70	5.64	60.12	16.44	5.64	2.70	1.23	16.20
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	4.62	35.42	1.54	7.70	43.12	10.78	9.24	3.08	0.00	7.70
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	11.82	39.75	1.07	3.94	60.52	13.25	7.16	2.15	0.36	13.97
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	33.24	2.77	4.15	34.62	19.39	11.08	4.15	1.38	6.92
CD8+ T Cells, donor1	11226-116C2	5.57	29.47	0.65	1.64	40.92	6.55	3.93	2.29	0.65	8.51
CD8+ T Cells, donor2	11307-117C2	3.75	13.14	1.13	1.88	41.30	3.38	3.38	0.38	0.75	3.75
CD8+ T Cells, donor3	11383-118B6	5.55	28.28	0.76	1.01	33.08	8.08	3.28	0.76	0.00	6.31
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	24.54	10.78	3.44	0.92	5.05	4.59	0.69	0.23	1.38	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.92	9.35	2.40	2.40	6.47	3.12	1.44	0.00	0.96	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	27.36	6.29	2.46	1.37	3.01	3.56	0.00	0.00	1.37	1.09
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	27.02	13.81	5.40	3.00	6.00	4.80	2.70	0.30	1.20	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.28	11.28	4.80	1.44	6.24	3.36	0.96	0.00	1.44	1.92
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.88	7.73	3.18	1.36	3.64	4.32	1.14	0.45	0.91	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	34.55	12.39	4.35	2.82	5.65	5.43	1.52	1.09	1.74	1.09
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	41.06	11.84	3.16	0.53	9.74	6.58	1.32	0.00	2.63	1.32
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	45.03	9.62	4.92	2.11	5.39	6.57	3.28	1.41	2.11	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	43.47	12.98	4.83	1.21	10.57	5.13	2.11	0.60	2.11	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	40.09	9.88	3.49	2.03	9.01	4.36	2.03	0.00	2.61	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	37.57	13.32	5.06	1.87	7.46	5.33	2.66	0.53	1.07	2.40
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.76	7.44	3.94	0.00	10.51	6.13	0.44	0.44	4.82	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	17.76	8.20	6.38	2.28	10.93	4.10	1.82	0.00	6.83	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	26.85	11.19	4.48	0.75	18.65	5.22	1.49	0.75	8.20	4.48
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	22.69	9.72	4.32	0.00	7.56	4.32	0.36	0.72	1.44	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.32	9.78	2.59	1.73	6.91	4.89	2.59	0.58	1.44	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	20.03	10.61	4.01	0.47	6.84	1.89	1.41	0.24	0.94	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	38.35	12.99	5.70	1.27	6.34	2.22	1.58	0.32	3.17	1.58
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	35.98	11.38	6.46	2.15	4.61	5.54	1.85	0.00	2.15	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	35.26	8.01	3.85	0.32	6.73	4.49	2.24	0.00	2.24	2.56
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	30.60	13.00	4.21	1.15	7.65	8.03	0.76	0.00	1.91	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.32	9.06	2.76	0.79	12.61	2.76	1.58	0.39	2.36	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.77	7.56	3.03	0.00	12.10	3.03	1.51	0.00	0.76	2.27
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	37.74	12.85	5.62	0.00	16.06	7.23	0.80	0.80	5.62	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	39.87	18.19	9.09	0.70	27.28	6.99	0.00	0.70	2.10	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	47.08	17.03	13.02	0.00	17.03	16.03	1.00	0.00	4.01	4.01
Cardiac Myocyte, donor1	11525-119I4	23.76	7.31	1.83	0.00	0.00	3.66	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	36.56	5.93	6.42	3.95	0.99	1.98	0.49	1.48	0.99	0.99
Cardiac Myocyte, donor3	11686-122I3	37.57	5.47	7.79	2.84	0.53	1.47	0.74	0.42	0.74	0.74
Chondrocyte - de diff, donor1	11261-116G1	60.32	9.71	6.93	2.77	0.69	1.73	1.04	0.00	1.04	0.35
Chondrocyte - de diff, donor2	11338-117F6	28.79	6.40	3.20	1.78	1.07	2.13	1.07	0.00	0.36	0.71
Chondrocyte - de diff, donor3	11410-118E6	46.88	3.87	3.98	1.48	0.68	1.71	0.80	0.68	0.57	0.23
Chondrocyte - re diff, donor2	11339-117F7	44.76	14.32	5.37	8.95	1.79	0.00	2.69	4.48	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	35.18	8.09	2.83	6.07	0.81	1.21	1.62	2.83	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	38.44	4.82	3.44	5.85	0.57	2.41	1.03	1.72	0.46	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	35.27	3.42	3.85	1.92	0.21	0.86	0.00	0.21	0.43	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	33.28	4.69	5.13	2.65	0.53	1.59	0.88	0.09	0.35	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	74.00	18.25	4.68	20.08	2.11	6.05	2.57	2.93	1.28	1.83
Corneal Epithelial Cells, donor1	11526-119I5	49.84	7.47	18.44	8.78	0.44	3.07	1.76	2.85	2.85	0.00
Corneal Epithelial Cells, donor2	11606-120I4	52.33	6.83	23.89	9.10	2.28	6.83	0.00	0.00	6.83	0.00
Corneal Epithelial Cells, donor3	11687-122I4	51.38	8.18	19.17	5.62	1.28	2.56	0.51	1.28	4.09	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.04	6.77	3.30	5.94	2.15	2.97	0.83	0.83	1.16	0.99
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	28.07	6.94	2.52	5.05	1.89	1.58	1.58	1.89	1.26	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	6.90	6.90	6.90	0.00	0.00	3.45	3.45	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	30.24	6.05	4.21	3.78	2.05	2.16	1.19	1.19	0.76	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	23.91	15.03	2.39	6.15	6.83	1.37	0.68	0.68	0.00	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	16.97	7.18	0.00	8.49	7.83	2.61	0.00	1.96	0.65	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	19.36	14.03	0.48	5.32	4.84	2.42	1.94	0.97	0.97	2.90
Endothelial Cells - Aortic, donor0	11207-116A1	35.02	5.00	7.84	2.67	1.17	2.00	1.33	1.67	2.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	24.64	4.69	4.69	1.17	0.59	1.17	0.00	1.17	0.00	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	45.25	6.50	6.79	5.09	1.41	1.13	0.28	1.41	2.83	0.85
Endothelial Cells - Aortic, donor3	11412-118E8	30.28	3.54	4.72	1.57	0.39	1.57	0.79	0.39	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	57.88	5.82	8.73	4.07	0.58	2.33	0.58	1.16	1.75	0.29
Endothelial Cells - Artery, donor2	11341-117F9	48.94	5.65	7.29	1.88	0.47	1.88	0.71	0.24	1.65	1.41
Endothelial Cells - Artery, donor3	11413-118E9	34.01	5.96	7.01	2.63	1.40	1.58	0.35	2.10	1.75	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	41.45	3.99	6.21	1.77	0.00	1.11	0.44	0.00	0.44	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	47.16	7.00	5.78	3.35	0.61	0.91	0.91	0.00	1.52	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	35.24	3.95	6.20	1.41	0.56	1.41	0.00	1.41	1.13	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	40.11	8.32	8.91	2.97	0.00	1.19	0.00	0.30	2.38	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	25.51	3.64	11.45	1.04	0.52	1.04	0.00	0.52	1.56	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	39.13	4.68	8.22	1.70	0.57	0.57	0.57	0.71	1.99	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	49.21	8.00	12.40	1.60	0.00	1.60	0.40	1.20	2.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	34.07	4.19	4.19	2.10	0.00	1.05	0.52	1.05	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.01	3.48	8.32	3.35	0.75	1.99	1.37	1.74	1.99	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	22.60	4.35	7.17	2.82	1.52	1.52	0.87	0.22	1.09	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	23.57	5.98	4.64	2.32	0.73	1.71	0.12	1.10	1.34	0.00
Endothelial Cells - Vein, donor1	11267-116G7	31.85	9.10	6.83	2.28	1.14	2.28	0.00	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	39.81	10.48	6.29	2.10	0.70	2.79	0.00	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	32.66	4.87	6.28	2.51	1.57	1.41	0.63	0.47	0.63	0.47
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	30.49	0.00	15.25	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	3.30	41.26	1.65	1.65	36.31	8.25	14.85	3.30	1.65	3.30
Eosinophils, donor3	12246-129H5	7.13	28.53	3.57	7.13	32.10	21.40	10.70	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	40.80	5.86	23.70	5.13	0.49	1.95	0.73	0.73	2.44	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	52.00	12.48	27.04	4.16	0.00	0.00	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	81.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	32.54	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	38.18	5.34	5.75	4.11	0.82	1.23	0.82	2.46	2.46	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	40.51	1.97	9.96	1.31	0.55	0.22	0.33	0.11	1.97	0.33
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	54.60	3.47	10.40	1.73	1.19	1.63	0.98	0.65	2.28	0.33
Fibroblast - Aortic Adventitial, donor1	11245-116E3	51.91	5.09	8.61	2.06	0.49	2.06	1.09	0.73	1.58	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	31.93	4.91	3.28	6.28	1.09	1.77	0.68	0.96	0.68	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	39.02	3.90	5.48	1.79	0.63	1.16	0.74	0.42	1.48	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	51.38	12.65	4.22	4.48	1.32	4.48	2.63	2.11	0.26	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	48.50	7.31	6.64	3.32	0.00	2.33	2.33	0.66	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	28.12	3.63	5.90	2.72	0.00	0.91	0.45	0.00	1.36	0.45
Fibroblast - Cardiac, donor2	11345-117G4	25.77	6.82	3.03	0.76	0.00	0.76	0.00	0.76	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	32.96	3.00	9.31	2.21	0.63	1.10	0.32	0.79	1.89	0.63
Fibroblast - Cardiac, donor4	11452-119A3	36.68	5.46	4.55	3.03	0.30	1.82	0.61	0.30	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	29.06	4.95	5.84	1.78	1.40	2.16	1.02	0.51	0.63	0.38
Fibroblast - Cardiac, donor6	11460-119B2	28.04	5.61	4.55	2.27	0.30	1.82	0.91	0.45	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	65.92	10.45	4.29	4.29	1.07	2.68	1.61	0.67	1.07	1.21
Fibroblast - Choroid Plexus, donor2	11572-120E6	37.53	2.59	2.16	0.86	0.43	1.29	1.29	0.00	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	23.44	2.93	2.93	1.46	0.00	1.46	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	72.88	18.91	5.77	4.61	0.92	6.69	1.85	0.69	0.23	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	68.18	4.41	4.24	2.54	0.51	1.87	0.51	0.17	0.51	1.02
Fibroblast - Dermal, donor1	11269-116G9	34.75	5.63	4.23	2.35	0.23	1.17	0.70	0.70	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	33.02	7.08	4.72	4.25	0.47	2.83	1.89	1.42	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	29.01	4.11	3.38	1.81	0.60	1.57	1.09	1.09	0.24	0.24
Fibroblast - Dermal, donor4	11450-119A1	30.18	5.88	2.15	4.41	0.45	1.70	0.57	0.79	0.34	0.23
Fibroblast - Dermal, donor5	11454-119A5	30.35	5.58	2.79	2.62	0.70	1.57	1.22	0.87	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	38.17	5.85	3.41	6.17	0.32	2.44	1.95	0.65	0.16	0.32
Fibroblast - Gingival, donor1	11237-116D4	42.48	5.00	6.04	2.29	0.83	0.83	0.62	0.42	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.02	4.98	8.91	3.14	1.05	1.05	1.83	0.52	1.05	1.57
Fibroblast - Gingival, donor2	11318-117D4	43.36	4.61	5.80	3.95	0.66	2.24	1.19	0.26	0.79	0.26
Fibroblast - Gingival, donor3	11394-118C8	43.22	6.19	5.12	1.84	1.26	1.84	0.68	0.58	0.58	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	28.05	2.08	1.04	2.08	0.00	2.08	1.04	0.00	1.04	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	29.43	1.59	1.76	2.82	0.18	1.06	0.18	0.70	0.53	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.79	6.86	4.52	2.81	0.62	3.90	1.40	1.40	1.09	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	29.89	4.06	4.60	2.84	0.54	1.49	1.08	0.27	0.68	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	38.11	7.06	7.06	3.88	1.06	4.23	1.41	1.06	2.47	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	32.32	4.97	3.66	1.75	1.02	1.32	0.73	0.73	0.88	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	41.86	6.95	5.45	2.32	0.82	2.32	1.91	1.09	1.50	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.87	7.57	5.16	3.18	1.86	2.08	1.54	0.99	0.88	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	51.95	4.11	2.35	2.49	1.17	2.20	1.17	0.59	0.00	0.88
Fibroblast - Lung, donor1	11270-116H1	33.98	5.44	4.08	0.00	1.36	2.72	0.00	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	34.32	5.97	2.98	4.48	0.00	4.48	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	48.54	7.18	2.11	2.74	0.42	2.11	2.32	0.63	0.42	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	116.62	3.33	8.33	7.50	0.83	5.00	2.50	0.00	2.50	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	39.16	8.39	8.39	8.39	0.00	2.80	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	46.18	5.04	5.04	2.80	0.28	0.84	0.84	0.56	1.40	0.00
Fibroblast - Mammary, donor1	11540-120B1	61.30	10.15	4.47	8.53	0.41	4.06	0.81	1.22	2.03	0.81
Fibroblast - Mammary, donor2	11620-122A9	35.95	11.98	3.99	3.99	0.00	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	41.69	17.87	11.91	5.96	0.00	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	30.45	5.63	2.13	5.24	0.19	1.16	1.55	0.58	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.13	6.52	4.70	4.10	0.61	3.34	1.06	0.61	0.76	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	38.86	4.90	3.67	3.06	0.92	1.53	1.22	1.22	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	25.95	5.34	3.05	1.53	0.38	0.76	0.00	0.38	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	25.38	2.97	0.81	1.35	0.54	1.35	0.00	0.81	0.81	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.04	4.41	1.62	3.02	0.46	0.81	1.04	1.39	0.23	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	42.00	5.20	8.84	4.20	0.99	1.55	0.99	0.99	2.10	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	47.95	10.97	6.71	4.47	0.81	4.27	1.63	1.83	1.42	1.42
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	42.10	7.35	3.34	3.34	0.67	3.34	3.34	0.67	0.00	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	38.35	5.54	3.16	1.98	0.40	1.98	0.79	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	30.96	7.34	2.18	3.97	1.59	3.97	0.60	0.40	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	27.53	3.02	1.07	1.42	0.53	1.07	0.53	0.36	0.00	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	23.26	1.97	1.77	2.37	1.18	0.99	0.39	0.79	0.00	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	41.82	6.32	4.21	4.51	1.50	3.31	0.60	1.81	0.60	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	43.18	5.18	2.59	2.05	0.97	2.05	1.08	0.54	0.54	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	26.07	5.31	2.28	2.53	0.00	1.27	1.27	1.52	0.25	0.51
Fibroblast - skin normal, donor1	11553-120C5	29.37	3.77	3.61	3.12	0.66	1.31	0.16	0.98	0.98	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	29.07	7.62	5.01	5.81	1.20	3.21	0.60	3.81	0.80	0.20
Fibroblast - skin normal, donor2	11561-120D4	28.33	3.32	3.72	1.61	0.50	1.61	0.40	0.30	1.11	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	28.11	5.14	2.42	2.72	1.51	1.21	1.21	0.30	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	26.51	1.99	0.99	1.49	0.33	0.66	0.75	0.50	0.17	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	58.98	6.33	3.93	2.22	1.03	1.54	0.34	0.68	0.00	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.20	6.90	3.94	5.91	0.33	2.30	1.64	0.33	0.33	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	34.94	5.75	4.90	3.52	0.43	1.17	1.07	0.64	0.96	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	36.10	5.74	4.55	3.37	0.34	2.70	1.01	1.01	0.84	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	35.75	2.51	6.27	2.98	0.16	1.41	0.63	0.78	1.25	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	22.16	44.32	0.00	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	61.01	4.36	16.56	6.10	1.74	2.61	0.87	1.74	3.49	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.93	1.56	15.43	3.47	1.04	0.87	0.52	1.39	3.99	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	27.85	3.38	11.71	7.81	0.78	1.82	0.26	2.08	4.16	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	33.47	3.58	13.54	6.64	0.26	2.81	0.00	0.51	5.62	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	60.48	10.72	29.86	17.61	1.53	6.89	3.06	6.89	5.36	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	61.25	9.57	19.78	21.06	3.19	7.02	2.55	5.10	6.38	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	72.74	12.55	23.96	37.94	2.00	4.28	2.28	5.71	1.43	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.57	10.48	5.24	38.88	1.10	4.41	2.21	4.41	0.83	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	37.67	9.36	5.25	13.47	1.14	2.51	3.65	1.60	0.46	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.67	9.91	17.24	27.14	1.39	4.56	3.17	3.76	2.38	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	35.16	6.87	6.61	32.51	0.26	3.97	2.91	2.91	1.06	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	43.38	7.50	5.87	13.70	0.00	1.30	3.26	1.63	0.98	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	67.22	24.32	23.00	23.44	2.21	7.96	2.65	3.98	4.42	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	43.39	7.35	18.23	34.77	0.57	4.38	2.69	5.65	0.71	0.57
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	48.03	7.51	19.58	26.97	0.74	3.57	1.85	5.30	1.35	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	45.40	11.01	17.73	27.13	1.61	5.10	3.49	7.52	3.49	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	41.13	5.08	15.24	12.76	0.12	2.60	1.12	2.11	1.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.39	6.09	16.61	15.50	0.55	2.91	2.21	1.80	1.80	0.14
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	43.91	4.68	19.72	15.45	0.81	3.86	1.42	1.42	1.22	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	49.74	4.79	13.46	13.46	0.91	3.65	1.37	2.05	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	42.10	5.61	15.20	10.96	0.37	1.74	1.00	2.49	1.00	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	45.90	6.34	13.55	17.70	0.22	1.75	1.53	2.40	2.19	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	38.71	5.02	8.86	16.25	1.48	2.36	1.18	2.95	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	36.08	6.68	9.22	11.60	0.32	3.18	1.75	1.75	0.32	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	44.46	5.81	17.87	19.88	0.89	1.79	2.90	4.24	0.89	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	33.27	8.07	6.25	8.47	0.60	2.62	1.01	2.42	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	34.44	6.45	9.50	10.69	0.85	2.21	0.51	2.04	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	47.71	6.56	15.52	15.96	0.80	1.77	2.04	3.28	2.57	0.98
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	51.92	6.97	5.10	17.07	0.31	3.85	1.66	2.81	0.42	1.04
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.99	7.51	3.93	17.25	0.85	3.07	1.71	2.90	0.00	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	33.09	6.86	5.09	10.62	0.33	3.10	1.11	1.55	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	42.43	5.66	8.07	13.73	1.16	3.41	1.50	2.66	1.58	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.14	6.13	6.33	15.52	0.00	2.65	2.25	2.65	1.63	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	37.96	5.16	4.75	11.14	0.62	1.44	1.24	1.44	0.41	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.39	6.46	3.57	11.18	0.69	2.42	1.61	1.38	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.52	7.34	4.00	10.67	1.00	2.50	1.50	1.67	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	36.81	5.73	2.42	9.92	0.00	2.42	1.10	1.32	0.22	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	43.79	6.03	3.94	11.81	0.74	2.83	1.48	1.23	0.25	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	34.53	6.16	4.38	9.73	0.97	3.73	1.13	1.95	0.49	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	48.11	4.81	4.49	9.94	0.96	1.28	1.60	1.92	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	36.10	6.35	4.93	7.96	0.66	2.27	1.04	1.23	0.09	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	39.70	5.54	4.75	8.07	1.11	2.06	1.58	1.74	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	42.88	8.51	3.34	7.60	1.22	2.13	1.82	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	41.92	7.63	4.70	6.69	0.73	2.51	1.46	2.09	0.52	0.84
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.98	5.27	4.83	8.12	0.66	2.20	0.66	0.88	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	46.85	5.89	3.65	10.10	0.28	3.93	0.84	1.40	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	29.07	7.04	4.72	3.15	0.83	2.13	1.11	1.11	0.46	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.78	6.69	4.28	3.74	1.07	2.14	1.87	1.07	0.27	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	37.03	5.05	6.27	4.74	1.38	1.38	0.92	0.61	0.92	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	36.14	5.83	6.35	3.89	1.30	3.37	0.78	0.78	0.26	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	44.46	5.15	4.07	3.25	0.54	2.17	1.63	0.27	0.81	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.99	4.61	4.06	2.77	0.74	2.21	2.77	0.55	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	45.18	6.14	2.85	3.29	1.54	2.85	1.54	0.88	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	85.29	6.94	2.98	3.97	1.98	4.96	0.99	2.98	0.00	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	37.33	4.75	5.01	2.77	1.19	1.06	1.06	0.79	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	33.49	3.63	3.43	2.22	0.81	2.02	0.81	0.81	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	156.56	15.76	12.20	11.95	3.30	7.37	2.80	2.03	1.02	4.07
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	57.73	11.15	17.72	54.34	0.60	5.77	2.99	7.37	1.79	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	32.36	7.24	15.56	47.46	1.08	5.55	2.77	7.55	0.92	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	42.35	10.64	14.93	42.14	0.20	3.27	4.09	8.39	1.43	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	51.01	4.69	25.66	22.84	2.50	3.76	2.19	7.82	3.44	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	45.77	9.61	18.37	22.89	0.85	7.06	1.98	3.67	6.22	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	46.12	7.38	12.45	30.44	0.46	2.77	1.38	1.38	2.31	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	9.90	19.80	17.32	0.00	12.37	14.85	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	42.94	8.90	15.47	23.21	0.77	3.48	2.32	3.48	2.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	57.76	8.02	24.07	16.04	1.60	4.81	0.00	4.81	9.63	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	6.96	12.17	22.60	0.00	3.48	3.48	3.48	3.48	5.22
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	40.68	7.81	13.34	17.25	0.98	6.84	4.88	3.58	1.95	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.83	6.59	11.53	19.77	0.82	2.47	1.24	3.29	1.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	19.99	13.33	10.00	23.33	0.00	10.00	3.33	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	36.91	6.43	11.19	15.66	0.28	3.64	1.68	3.64	1.12	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	47.07	6.86	12.75	14.05	1.31	3.92	1.31	3.92	2.61	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	34.39	11.74	5.03	15.10	0.00	1.68	0.84	2.52	1.68	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	34.35	5.41	6.68	17.18	0.00	3.18	3.50	3.18	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	34.65	4.42	8.49	18.34	0.34	4.08	3.40	4.08	0.68	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	12.53	6.26	16.71	0.00	8.35	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	37.23	5.15	6.30	17.75	0.57	1.72	1.15	1.15	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.81	6.81	5.92	16.87	0.30	1.18	1.48	1.78	0.00	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	20.33	8.47	8.47	10.16	0.00	3.39	0.00	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	38.52	7.04	10.77	12.43	1.66	3.31	1.24	1.66	2.07	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	36.13	11.51	7.36	13.81	1.61	5.75	1.84	3.45	1.15	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	31.61	5.27	5.27	10.54	0.00	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	29.22	3.08	6.15	9.61	0.00	3.08	0.38	3.08	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	35.53	8.15	10.11	6.85	0.65	4.24	1.63	1.30	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	46.15	2.68	5.35	14.05	1.34	1.34	0.00	2.01	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	34.29	4.24	6.16	19.65	0.39	3.08	0.00	1.16	1.16	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.63	9.24	6.50	12.67	1.71	3.77	2.05	2.40	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	29.82	2.48	4.97	22.36	0.00	0.00	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	28.31	4.72	0.94	17.46	0.00	0.94	0.94	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	40.43	3.02	3.62	12.07	0.60	1.81	0.00	1.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.71	5.60	7.12	13.23	0.00	3.05	0.00	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	32.70	6.78	6.78	14.76	0.40	2.39	0.00	0.40	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	34.04	4.44	5.43	14.80	1.97	2.96	1.48	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	3.54	4.72	18.89	0.00	0.00	2.36	3.54	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.67	2.33	4.67	18.67	0.58	0.58	0.58	3.50	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	40.38	3.07	4.83	21.94	0.00	2.19	0.88	3.51	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	17.80	3.39	2.54	13.56	0.85	3.39	0.00	1.70	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	32.23	3.58	4.18	11.34	0.00	1.79	2.39	0.00	1.19	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	38.82	2.91	6.79	10.68	0.49	4.85	1.46	2.43	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	18.26	10.27	1.14	3.42	0.00	2.28	0.00	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	21.62	4.57	1.25	1.25	0.42	0.42	1.25	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	28.11	4.50	2.25	2.25	0.00	1.12	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	28.86	5.07	2.85	0.63	1.27	0.63	0.63	0.32	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	48.46	2.92	4.18	0.42	0.00	1.25	0.42	0.42	2.09	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	88.42	9.63	31.10	21.00	1.04	7.31	4.53	3.95	5.11	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	86.43	11.31	27.51	21.44	1.01	6.75	4.90	4.22	3.88	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	67.80	10.01	20.93	16.38	1.37	7.05	5.01	3.19	2.50	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	90.07	9.51	28.75	22.08	0.55	4.92	4.48	4.59	5.25	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	82.10	9.67	29.44	21.49	1.72	6.66	7.52	3.87	4.51	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	74.92	7.53	19.38	17.22	2.15	5.60	4.31	4.09	3.88	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	100.63	9.46	30.89	18.81	1.49	6.73	5.48	5.11	4.98	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	82.34	9.61	28.48	20.76	1.89	7.38	5.32	4.97	4.46	1.03
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	65.68	12.17	23.71	16.98	0.64	8.33	3.20	4.16	4.16	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	50.93	7.83	5.04	1.12	1.68	0.00	0.00	0.00	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	40.68	5.63	6.92	3.90	2.60	0.87	2.60	0.43	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	10.58	0.00	2.64	0.00	10.58	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	52.20	9.52	4.59	3.53	0.00	2.12	1.76	0.71	3.17	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	59.57	4.36	8.72	3.63	0.00	3.63	0.00	0.00	1.45	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	36.02	5.25	6.47	3.67	0.70	2.80	0.87	1.40	0.87	0.17
Hepatocyte, donor1	11523-119I2	69.00	19.37	10.90	6.05	0.00	3.63	0.00	2.42	2.42	0.00
Hepatocyte, donor2	11603-120I1	40.94	8.62	18.31	8.62	1.08	3.23	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	66.88	14.72	6.75	13.50	0.61	5.52	1.23	1.23	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	7.83	16.97	0.00	0.65	41.12	2.61	0.00	0.65	0.00	8.48
Intestinal epithelial cells (polarized), donor1	11246-116E4	23.77	4.72	14.68	5.24	1.22	1.75	1.05	2.10	2.80	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	40.61	3.02	4.80	3.43	0.27	0.96	0.82	0.69	0.69	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	50.94	9.55	9.55	15.92	3.18	0.00	0.00	0.00	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	13.35	6.68	13.35	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	47.07	9.69	2.77	18.00	0.00	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	55.06	12.51	15.02	12.51	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	0.00	11.87	0.00	0.00	0.00	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	5.13	10.25	7.69	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	13.71	4.57	9.14	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	58.48	11.37	6.50	11.37	1.62	0.00	1.62	3.25	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	6.67	10.00	15.01	3.33	0.00	0.00	0.00	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	7.26	7.26	7.26	3.63	0.00	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	9.26	11.91	18.53	7.94	1.32	1.32	3.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	37.69	5.54	13.30	11.09	2.22	2.22	0.00	1.11	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	20.95	5.24	26.19	10.48	0.00	5.24	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	54.80	5.04	8.19	13.23	1.26	1.89	1.89	1.89	0.63	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	6.19	4.64	7.73	0.00	0.00	0.00	3.09	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	48.45	7.75	7.11	13.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	43.47	9.66	4.83	16.10	0.00	3.22	3.22	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	11.95	0.00	11.95	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	47.26	8.96	11.41	8.96	3.26	0.81	0.81	3.26	0.81	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	44.08	5.46	4.20	15.11	2.94	2.10	0.42	1.26	0.84	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	41.79	9.64	4.82	9.64	1.61	2.41	0.80	1.61	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	34.16	5.54	3.69	9.23	1.85	0.92	1.85	1.85	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	34.93	5.66	8.02	5.19	2.36	1.42	0.94	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	2.72	4.53	8.16	1.81	0.91	0.91	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	0.00	0.00	14.74	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	41.97	3.23	8.61	6.46	0.00	3.23	1.08	1.08	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	60.98	6.35	6.35	11.43	0.00	6.35	1.27	0.00	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00	16.43	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	55.48	9.57	5.74	6.38	2.55	1.91	0.64	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	5.47	7.29	12.76	1.82	1.82	0.00	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	15.80	0.00	15.80	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	48.56	4.28	10.00	11.43	2.86	5.00	0.00	0.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	3.32	6.64	3.32	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00	20.85	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	39.82	5.25	4.32	6.48	1.54	0.93	1.23	0.93	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	61.46	8.78	3.51	12.29	1.76	3.51	1.76	3.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	6.29	3.14	9.43	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	47.29	7.65	5.56	13.91	1.39	3.48	1.39	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	48.69	8.85	11.07	17.70	4.43	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	68.08	0.00	9.73	12.97	0.00	3.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	58.42	7.85	10.46	6.10	0.87	0.87	0.00	0.00	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	74.24	6.75	4.50	0.00	2.25	2.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	3.48	17.42	3.48	0.00	0.00	0.00	0.00	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	69.34	3.20	14.93	6.40	1.07	3.20	0.00	3.20	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	16.63	13.85	15.24	1.39	1.39	0.00	1.39	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	2.85	11.40	14.25	2.85	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	50.62	4.60	13.81	12.89	0.00	2.76	0.92	2.76	2.76	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	60.51	9.08	3.03	24.20	3.03	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	37.25	6.21	12.42	12.42	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	57.10	1.06	9.52	8.46	3.17	1.06	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	66.91	4.00	16.97	5.22	1.55	1.63	1.06	1.47	4.90	0.82
Keratinocyte - epidermal, donor2	11349-117G8	33.38	6.44	16.40	2.93	0.59	0.59	0.00	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	35.87	10.60	13.73	3.12	0.66	2.27	0.19	0.57	3.03	0.28
Keratinocyte - oral, donor1	11251-116E9	52.67	5.45	22.36	9.19	0.57	2.16	0.57	1.59	2.61	0.57
Keratocytes, donor1	11527-119I6	67.39	24.07	6.53	2.06	0.69	2.75	1.03	0.34	0.00	1.03
Keratocytes, donor2	11607-120I5	51.56	4.69	7.03	11.72	1.17	3.52	1.17	2.34	1.17	0.00
Keratocytes, donor3	11688-122I5	36.36	9.88	2.17	2.17	1.58	1.78	0.79	0.79	0.20	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	6.59	2.20	21.98	0.00	6.59	2.20	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	29.13	5.39	5.39	6.47	1.08	1.08	0.00	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	49.94	6.23	2.19	7.15	0.58	2.65	1.73	0.69	0.00	0.46
Lens Epithelial Cells, donor3	11690-122I7	38.24	3.63	3.94	3.53	0.91	1.61	0.81	1.21	1.41	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.81	5.22	7.83	3.20	0.71	1.78	0.71	0.71	1.30	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	30.70	3.63	5.86	1.67	0.00	0.84	0.84	0.56	1.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.00	3.31	8.03	2.05	0.31	1.42	0.63	1.10	2.52	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	3.76	4.30	1.61	0.54	2.15	0.54	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	27.42	3.78	6.30	2.52	0.63	1.58	0.95	1.26	1.89	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	34.18	3.13	7.22	2.48	0.75	0.54	1.19	0.97	1.83	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	22.16	3.69	6.16	2.05	0.00	1.23	0.41	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	38.43	3.29	8.34	2.53	0.25	1.77	0.51	0.25	0.76	0.51
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	36.17	2.96	6.05	2.11	0.28	1.13	0.56	0.28	1.69	0.42
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	26.90	1.58	3.16	2.77	1.19	2.77	0.79	1.19	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	30.44	3.49	7.17	3.10	0.58	1.16	0.78	0.78	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	35.18	3.15	4.63	2.96	0.00	1.48	0.74	0.74	2.22	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	33.80	3.48	6.27	2.09	0.00	1.39	0.35	1.05	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	38.64	2.39	10.02	2.62	0.00	1.43	0.72	1.91	1.19	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	34.06	2.06	7.42	1.92	0.27	1.51	0.55	1.10	1.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	3.08	4.62	1.85	0.62	1.23	0.00	0.62	0.62	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	31.49	2.49	9.35	3.74	0.31	1.87	0.62	0.31	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	37.70	1.46	10.61	1.46	0.37	1.83	1.28	0.73	2.20	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.71	3.29	3.95	1.97	0.33	0.66	1.32	0.33	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	36.61	1.46	7.32	2.34	0.88	0.59	0.59	0.29	0.88	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	41.57	3.49	6.97	2.74	0.25	0.25	0.50	0.75	1.74	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	23.76	3.39	4.85	1.94	0.48	0.48	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	38.51	4.31	6.19	2.15	0.00	1.08	1.35	1.08	1.08	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	31.18	4.24	9.23	2.12	0.45	1.06	0.76	0.15	1.06	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	25.92	2.07	6.74	1.04	0.52	0.52	1.04	1.04	2.59	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.52	2.93	6.07	2.30	0.63	1.26	1.05	0.42	0.63	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	29.32	2.11	7.52	2.11	1.20	0.60	1.05	0.30	1.80	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	26.83	3.44	10.32	2.75	0.00	1.38	2.06	0.00	1.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	30.67	2.45	7.53	1.51	0.75	0.56	0.38	0.56	0.56	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	32.13	3.50	5.83	2.97	0.53	1.70	0.85	1.38	1.59	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	0.97	5.33	1.94	0.48	1.45	0.48	1.45	1.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	31.42	4.96	5.62	3.31	0.33	1.32	1.32	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	32.09	2.60	7.43	2.85	0.25	1.24	0.74	0.37	1.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	33.32	3.33	5.92	1.85	0.37	0.00	1.48	0.37	1.48	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	33.60	2.47	7.66	2.96	0.00	1.48	0.74	0.49	0.99	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	35.20	2.06	8.11	3.99	0.55	0.82	0.14	0.55	1.51	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	28.95	2.89	4.82	1.29	0.64	1.29	0.64	0.64	1.61	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.61	2.74	6.70	1.83	0.30	0.91	0.00	0.61	1.52	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	33.59	2.52	7.28	2.94	0.42	1.68	0.42	0.42	1.54	0.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	27.73	2.49	4.62	3.56	0.71	1.42	1.07	0.00	1.78	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	35.87	2.91	3.88	0.97	0.48	1.45	0.48	0.00	2.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	34.86	2.49	6.07	3.11	0.00	0.62	0.62	0.62	1.56	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	31.51	1.07	3.58	1.43	0.36	1.43	0.72	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	32.99	2.29	4.90	2.29	0.00	1.96	0.65	0.00	0.65	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	35.31	2.59	7.06	3.53	0.24	1.41	0.71	0.47	1.41	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.53	5.07	5.82	4.33	0.50	1.86	0.99	1.24	1.86	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.45	2.56	5.12	2.31	0.51	0.77	1.02	1.02	1.79	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.27	3.28	6.27	1.49	1.19	0.90	0.60	0.90	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	56.65	6.80	20.39	2.27	0.00	2.27	2.27	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.88	10.74	16.11	7.67	3.07	3.07	3.07	1.53	2.30	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	48.99	14.10	22.27	4.45	0.74	3.71	3.71	2.23	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	59.24	9.73	21.58	2.96	1.27	4.23	3.81	2.54	4.23	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	68.93	17.58	21.10	5.63	1.41	6.33	2.11	1.41	2.11	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	70.05	16.81	15.88	3.74	0.00	7.47	5.60	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	58.23	5.67	31.43	3.09	1.03	4.12	3.61	3.09	1.55	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	48.77	15.46	19.03	8.33	2.38	3.57	1.19	2.38	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	69.89	11.99	19.23	5.20	2.49	5.20	1.13	1.36	4.30	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.09	8.72	16.58	5.23	1.16	1.16	2.33	1.74	3.20	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	44.57	7.20	14.86	3.60	0.45	3.60	0.90	2.25	3.60	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	71.27	12.33	25.06	7.05	2.17	3.93	2.57	1.63	4.34	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	66.24	7.70	17.46	6.68	1.54	5.65	3.59	1.03	4.62	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	52.58	10.59	9.17	6.00	1.06	2.12	1.06	2.82	3.18	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	37.31	6.66	13.33	7.33	1.33	2.67	4.00	1.33	3.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	58.07	11.21	19.36	6.11	1.53	3.06	2.04	2.55	3.57	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	47.49	15.21	17.88	4.80	1.87	2.67	2.67	3.47	1.33	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	53.85	13.23	15.87	5.10	1.51	2.83	2.27	1.51	2.83	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	66.88	5.52	13.50	3.68	1.84	2.45	1.84	1.23	3.07	2.45
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	69.31	18.75	12.23	2.45	0.82	4.89	0.82	3.26	4.08	3.26
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	49.77	11.87	19.99	7.29	1.25	3.96	1.87	1.25	1.46	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	58.85	6.73	14.85	4.48	2.24	3.36	0.56	0.56	2.52	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	75.21	14.42	17.52	9.27	1.03	6.18	3.09	4.12	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	49.06	10.74	18.00	5.81	1.45	3.48	1.16	1.74	3.19	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	46.63	6.88	13.75	4.48	1.79	2.99	2.09	0.60	3.29	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	49.79	14.38	16.04	4.98	1.66	2.77	2.21	1.11	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	64.33	10.25	25.10	8.48	0.71	3.18	1.77	3.18	5.30	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	54.58	8.11	21.39	3.69	1.48	3.32	2.58	0.74	3.69	1.84
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	54.11	10.36	14.97	5.76	2.30	4.61	0.00	0.00	2.30	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	64.09	11.13	18.42	6.91	2.30	4.61	1.92	1.92	1.92	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	58.31	8.49	17.55	3.96	1.70	1.13	2.26	1.13	7.36	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	55.79	10.67	18.87	4.92	3.28	3.28	3.28	1.64	3.28	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	73.21	11.30	18.08	7.23	1.81	3.62	3.62	2.71	1.81	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.89	7.90	12.93	5.75	0.72	3.59	3.59	0.00	2.87	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	55.27	11.95	18.67	8.22	1.49	4.48	1.49	0.75	4.48	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	63.17	9.29	20.44	7.43	2.23	4.09	1.11	3.34	3.34	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	67.20	7.75	21.97	6.46	1.72	3.45	3.45	1.29	2.15	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	59.08	6.85	17.98	7.71	0.86	3.43	4.28	0.86	3.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	62.64	7.00	21.32	3.66	1.67	2.67	1.33	1.33	2.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	53.09	7.84	16.89	6.64	2.41	4.83	1.81	1.21	3.02	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.86	9.24	24.88	7.82	1.42	2.13	2.13	1.42	2.13	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	57.40	8.25	19.25	6.19	2.06	3.09	3.09	0.69	0.69	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	58.51	5.90	16.64	3.76	1.07	0.54	3.22	0.54	2.68	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	59.93	10.77	28.95	4.71	1.35	2.02	2.69	2.02	3.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	58.89	10.74	20.00	4.07	0.74	3.70	0.74	2.22	3.70	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	50.01	6.98	20.93	4.65	0.00	0.00	1.16	0.00	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	52.89	8.46	10.58	4.23	3.17	1.06	2.12	2.12	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	54.42	8.00	20.41	1.60	2.00	2.40	2.80	1.60	2.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	55.97	5.81	17.44	6.54	1.45	4.36	2.18	1.45	5.09	2.91
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	67.45	17.63	19.93	8.43	2.30	3.83	1.53	3.07	3.07	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	69.06	10.36	22.20	7.40	3.95	7.40	1.48	0.99	2.47	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	51.75	6.59	16.00	3.76	2.82	3.76	4.70	2.82	2.82	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	64.86	21.12	18.60	5.03	1.51	3.52	1.51	2.51	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	58.13	16.22	20.73	6.31	1.80	2.70	1.35	2.70	3.15	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	61.96	5.16	13.77	3.44	1.72	0.00	1.72	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	58.34	16.92	19.15	7.57	1.78	6.68	0.45	1.34	1.34	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	59.83	8.99	19.16	4.69	0.78	3.13	3.52	1.96	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	77.85	7.92	15.83	6.60	0.00	3.96	1.98	0.66	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	52.41	16.61	21.28	5.19	1.56	4.67	1.04	0.52	4.15	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	53.38	10.06	25.82	7.00	1.75	1.31	1.31	4.38	3.50	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	52.00	9.50	14.54	1.68	1.68	2.24	1.68	2.24	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	60.06	19.43	18.11	6.18	2.21	3.97	0.44	0.88	2.65	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	54.00	14.27	18.51	6.94	1.54	3.86	2.70	3.09	3.86	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	38.99	8.10	17.22	4.56	2.03	1.52	1.01	1.52	4.56	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	20.19	16.34	5.77	2.88	1.92	1.92	1.44	1.92	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	58.44	12.32	21.87	10.34	1.19	2.78	2.39	1.19	2.39	1.19
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	48.00	7.90	13.37	5.47	1.22	3.65	1.22	0.61	3.04	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	62.94	9.68	23.52	5.53	0.69	2.08	1.38	0.69	2.77	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.06	13.68	19.00	4.18	2.28	4.18	1.52	0.76	3.80	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	55.77	9.30	15.49	4.13	2.07	2.07	1.55	2.07	4.13	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	57.44	7.26	29.02	3.63	0.00	3.63	0.60	1.81	4.84	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	52.61	9.82	18.06	5.07	2.85	4.12	0.63	2.22	3.80	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	54.38	8.53	15.99	2.13	1.60	2.67	1.07	2.13	5.86	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	78.73	12.07	28.16	4.02	1.15	1.72	0.00	2.87	4.02	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	61.71	7.71	16.46	4.63	3.60	3.09	1.54	2.57	2.57	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	64.37	7.07	16.98	5.66	1.41	1.41	1.41	0.00	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	73.77	9.65	22.70	6.24	2.84	2.84	3.40	1.70	6.81	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	74.05	13.31	24.96	5.41	0.83	2.50	2.50	0.83	2.08	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	68.12	7.83	27.41	2.35	2.35	1.57	2.35	0.78	3.13	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	78.08	8.35	28.81	3.76	2.09	2.92	2.51	3.34	3.34	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	61.80	13.47	21.84	4.18	0.93	3.25	2.32	1.86	3.72	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	58.21	7.36	24.09	3.35	2.01	2.01	4.68	2.68	4.01	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	67.90	8.55	31.01	4.28	0.53	2.67	0.53	0.00	4.81	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	61.02	6.87	30.31	5.25	2.83	5.66	2.83	2.42	2.02	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	51.39	10.10	15.60	2.75	1.84	0.92	0.92	0.00	4.59	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	75.57	8.00	33.79	6.22	2.67	0.89	4.45	0.00	2.67	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	54.71	11.40	22.79	6.27	3.42	1.71	1.71	0.57	4.56	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	54.45	10.74	18.41	2.30	1.53	0.00	1.53	0.77	2.30	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	70.04	5.47	30.64	3.83	1.09	5.47	1.64	0.00	7.11	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	56.57	4.45	19.60	3.56	1.78	3.56	2.67	0.00	5.79	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	66.29	6.24	30.41	7.28	2.08	3.38	1.30	2.34	5.46	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.30	11.94	29.84	4.64	1.99	1.99	2.65	2.65	3.98	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	66.52	6.24	33.26	6.24	2.08	6.24	0.00	2.08	6.24	2.08
Macrophage - monocyte derived, donor1	11232-116C8	24.16	13.90	1.37	3.19	2.05	2.05	0.91	0.91	0.46	1.82
Macrophage - monocyte derived, donor2	11313-117C8	28.08	10.83	2.57	4.59	1.47	2.02	1.65	1.10	0.18	1.28
Macrophage - monocyte derived, donor3	11389-118C3	25.69	8.26	1.84	2.75	1.70	1.44	1.70	0.52	0.52	1.18
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.68	3.72	13.28	2.12	0.00	1.06	0.53	0.53	3.72	1.06
Mallassez-derived cells, donor2	11929-125I3	36.60	4.75	8.56	8.08	0.63	1.58	1.11	0.63	5.07	0.32
Mallassez-derived cells, donor3	11930-125I4	30.02	4.17	8.34	5.14	0.42	1.67	0.42	1.39	3.06	0.14
Mammary Epithelial Cell, donor1	11273-116H4	67.96	9.17	17.64	4.88	1.69	3.39	1.30	1.69	4.09	0.40
Mammary Epithelial Cell, donor2	11350-117G9	54.15	7.53	21.14	7.24	0.58	3.76	1.16	1.16	4.05	1.16
Mammary Epithelial Cell, donor3	11422-118F9	40.66	5.49	19.46	4.49	0.75	2.00	0.50	1.00	2.99	0.25
Mast cell - stimulated, donor1	11487-119E2	25.76	12.88	1.36	4.75	13.56	3.39	0.68	0.00	0.68	2.71
Mast cell, donor1	11563-120D6	30.82	20.22	1.95	5.84	12.65	3.14	0.87	1.62	1.51	5.84
Mast cell, donor2	11565-120D8	17.24	30.61	1.78	12.78	9.21	3.57	4.46	6.24	0.59	5.65
Mast cell, donor3	11566-120D9	33.77	36.25	3.15	11.26	7.65	5.40	2.25	4.95	1.35	2.93
Mast cell, donor4	11567-120E1	26.24	34.04	3.01	14.71	8.33	3.72	1.95	5.14	0.53	5.14
Mast cell, expanded and stimulated, donor5	11940-126A5	63.32	25.62	2.99	12.86	21.29	4.66	1.33	4.10	0.78	8.21
Mast cell, expanded and stimulated, donor8	11942-126A7	42.61	15.18	2.92	4.67	14.59	3.50	2.33	0.00	2.92	5.84
Mast cell, expanded, donor5	11939-126A4	37.51	20.99	1.95	7.11	18.13	5.16	2.64	2.87	1.84	7.00
Mast cell, expanded, donor8	11941-126A6	41.67	21.76	4.35	6.86	22.76	3.85	1.51	0.84	1.51	5.19
Melanocyte - dark, donor1	11502-119F8	32.54	3.98	10.15	3.48	0.20	1.69	0.40	1.19	1.09	0.20
Melanocyte - dark, donor2	11582-120F7	34.95	4.85	7.27	0.69	0.00	1.73	1.38	0.00	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	55.78	22.02	6.09	9.85	3.19	5.00	1.52	1.67	1.23	2.46
Melanocyte - light, donor1	11274-116H5	64.88	16.93	5.64	4.70	3.53	2.12	1.18	1.65	1.41	2.35
Melanocyte - light, donor2	11351-117H1	57.33	9.55	8.87	2.05	1.36	6.14	2.73	0.68	0.68	0.68
Melanocyte - light, donor3	11423-118G1	45.96	6.94	6.07	1.73	0.87	1.73	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	56.64	12.29	9.16	4.17	1.67	2.92	2.19	1.77	0.83	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	65.62	5.38	9.41	3.23	0.81	1.88	1.08	1.08	4.03	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	63.48	11.52	6.43	5.09	1.34	4.29	0.80	0.80	0.27	0.80
Meningeal Cells, donor1	11493-119E8	59.42	11.66	7.44	8.31	0.62	4.47	1.98	2.36	0.87	1.74
Meningeal Cells, donor2	11573-120E7	49.30	14.08	4.84	4.84	0.88	2.64	1.32	2.20	0.88	2.20
Meningeal Cells, donor3	11654-122E7	48.66	6.76	4.73	4.48	0.73	2.20	0.90	0.73	0.90	0.57
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	39.92	4.85	4.56	5.13	0.00	0.86	0.57	0.57	0.29	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.55	4.83	5.64	2.31	0.91	1.61	1.21	0.50	1.11	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	98.56	9.20	11.83	2.63	1.31	5.26	3.94	0.00	0.00	2.63
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	66.72	3.92	3.92	3.92	0.00	2.62	0.00	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	28.70	3.59	5.74	1.44	0.00	1.44	1.44	1.44	0.00	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.07	4.24	3.81	1.48	0.64	2.33	0.42	0.42	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	42.22	5.03	5.53	1.51	1.01	2.51	0.50	0.50	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	61.53	8.79	5.05	7.47	0.88	3.74	1.98	2.86	0.66	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	52.60	6.58	5.11	5.84	0.73	5.11	2.19	2.19	1.46	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	57.08	8.80	10.43	7.16	1.23	2.46	1.02	2.66	0.82	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	49.72	5.12	4.29	2.08	0.28	1.25	0.83	0.55	0.28	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	63.94	6.32	3.35	8.18	1.12	2.23	1.12	0.74	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	53.81	3.95	5.53	2.11	0.39	1.45	0.92	0.66	0.00	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	46.88	6.53	2.67	3.26	0.59	2.97	0.89	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	4.67	4.67	2.34	2.34	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	56.36	9.61	7.04	1.92	0.00	0.64	1.28	1.28	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	31.19	7.09	1.42	3.54	0.35	2.13	1.42	2.13	0.35	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.91	5.00	4.07	3.44	0.00	2.19	0.31	0.63	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.03	9.43	2.18	7.26	0.73	2.90	0.00	2.18	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	71.86	4.77	12.46	5.30	0.80	2.39	1.06	0.27	4.24	0.80
Mesothelial Cells, donor2	12156-128G5	44.04	1.50	6.01	4.00	0.50	1.00	0.50	0.50	4.00	0.00
Mesothelial Cells, donor3	11402-118D7	56.08	4.05	9.25	3.11	0.65	1.52	0.43	0.43	3.90	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	6.75	1.35	1.35	0.00	0.00	0.00	1.35	1.35	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	22.16	9.60	1.23	5.17	1.48	3.45	0.74	1.48	0.00	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.69	7.36	3.53	3.24	2.06	3.53	1.47	0.59	2.36	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.22	6.20	1.55	2.79	0.93	2.79	0.62	0.93	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.08	6.43	2.90	3.32	1.24	0.62	1.24	0.62	1.45	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	2.32	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	38.54	7.01	2.75	2.25	1.25	1.75	0.75	1.50	0.50	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	32.58	5.12	4.19	0.93	1.86	1.40	0.47	0.93	2.79	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	28.25	5.28	2.85	2.85	0.81	1.02	0.41	1.42	0.00	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	28.51	7.13	2.38	1.98	2.38	3.17	1.58	1.19	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	28.32	9.73	1.77	5.31	1.77	0.88	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	38.37	6.08	7.60	4.18	0.76	1.90	0.76	0.76	2.66	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	3.95	0.00	1.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.07	6.79	1.91	4.24	0.64	1.06	0.42	1.70	0.42	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	17.50	2.76	3.68	0.92	0.00	0.00	0.92	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.18	7.15	0.89	2.09	0.60	1.49	0.30	0.60	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	3.35	3.35	0.00	1.68	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	19.57	7.78	2.76	3.76	2.01	1.51	0.75	0.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	27.33	2.85	2.61	1.90	2.61	0.95	0.24	0.48	1.43	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	2.21	0.00	0.55	0.00	0.00	0.00	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.04	7.83	0.69	2.53	1.61	2.30	1.15	0.46	0.46	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	28.61	5.47	6.73	2.10	1.47	2.73	2.10	1.47	1.26	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.90	6.52	2.04	2.65	2.24	1.02	0.82	0.20	0.20	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.45	6.22	1.93	1.29	1.93	2.15	1.07	0.64	0.21	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	20.23	5.56	2.22	1.78	2.00	1.11	1.11	0.89	1.33	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	12.70	7.01	1.10	1.75	0.88	1.10	0.88	0.44	0.00	0.66
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	13.69	2.53	0.00	1.52	0.00	0.00	1.01	1.01	1.52	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	12.50	8.70	0.27	1.63	2.45	1.09	0.27	0.00	0.82	1.09
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.88	2.65	3.23	2.35	0.59	1.47	0.88	0.88	2.06	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	7.63	1.09	1.09	1.09	1.09	0.00	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	19.70	6.73	0.00	1.92	1.44	0.48	0.00	0.48	0.00	1.92
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	25.21	7.20	3.20	2.80	0.80	1.20	0.00	0.40	1.20	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	2.74	1.37	0.00	1.37	2.74	0.00	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.52	5.51	3.00	2.00	1.50	1.50	0.00	0.50	0.00	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.70	3.50	1.31	0.00	0.44	0.88	0.00	0.88	0.44	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	2.21	3.31	1.10	1.10	0.00	0.00	1.10	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	3.84	0.64	0.64	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.88	6.20	1.49	1.74	0.74	1.98	0.99	0.74	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	3.48	4.87	0.70	0.70	0.70	0.00	0.00	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.23	4.10	0.68	1.71	0.34	2.74	0.34	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	7.00	3.94	2.63	4.38	0.44	1.31	0.44	1.75	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	1.78	1.78	0.71	1.78	0.00	0.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	11.78	3.09	0.56	2.52	0.84	3.09	0.84	1.12	0.84	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	4.16	1.66	1.25	0.83	2.08	0.83	0.42	1.25	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	1.17	2.33	0.00	0.58	0.58	0.58	0.00	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.26	4.22	0.30	2.11	0.90	2.11	0.00	0.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	22.96	5.43	7.51	2.09	1.67	3.34	0.83	1.25	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	6.46	0.92	1.85	0.00	0.92	0.00	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	6.26	3.98	4.55	1.71	1.71	1.71	0.00	1.14	1.71
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	8.29	3.59	1.11	2.21	0.69	0.55	1.52	0.83	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.44	2.33	1.30	2.59	2.07	1.81	0.78	0.26	1.04	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	21.02	4.72	3.43	1.72	1.72	1.29	0.86	0.43	2.57	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	4.45	2.54	0.00	1.91	0.00	0.00	0.00	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	7.21	2.94	1.33	1.87	0.00	1.87	0.00	0.53	0.27	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.76	7.78	4.49	2.10	0.90	2.99	1.20	0.30	2.10	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.07	4.24	1.27	0.57	0.85	1.13	0.28	0.14	0.71	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	10.19	2.55	0.96	1.59	0.00	2.55	0.00	0.32	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	24.99	5.53	7.52	5.09	1.55	3.10	0.22	1.33	4.42	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	7.20	3.03	2.28	1.14	0.76	1.14	0.38	0.38	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.81	3.13	0.85	3.69	0.28	2.27	0.57	0.57	1.70	0.85
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	26.30	4.42	6.88	3.69	2.46	3.44	0.00	2.21	2.46	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	1.30	0.00	0.00	0.00	0.00	1.96	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	9.41	3.53	0.88	2.94	1.76	1.76	0.59	0.88	1.18	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	20.76	3.46	6.92	3.17	1.15	2.02	1.44	1.44	5.48	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	12.36	2.89	0.41	1.24	1.65	1.65	1.24	0.41	0.00	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	9.53	5.06	1.19	2.08	0.00	2.38	0.60	0.89	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	26.37	11.30	0.00	0.00	0.00	7.53	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	8.91	3.56	5.35	1.78	1.78	0.00	0.00	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	26.61	15.11	3.61	2.63	1.31	2.30	1.64	1.31	0.00	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	10.52	3.16	1.05	3.16	3.16	0.00	2.10	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.54	8.50	0.99	1.38	1.98	0.79	0.40	0.79	0.40	2.17
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	32.60	16.76	0.93	2.79	0.93	3.73	3.73	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	23.66	16.90	3.00	3.00	2.25	2.25	3.38	1.13	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.71	11.99	2.40	1.33	0.80	2.40	0.53	0.27	0.53	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.44	9.05	0.57	2.26	1.36	2.04	1.13	0.23	0.11	1.13
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	16.21	11.05	0.74	2.95	2.21	1.47	1.47	1.47	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	22.35	16.86	1.10	1.47	1.47	1.47	1.83	0.73	0.00	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	7.78	1.56	3.11	4.67	1.56	0.00	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	27.79	8.02	1.60	3.21	1.60	3.21	2.14	0.00	0.00	2.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	23.18	38.64	0.00	0.00	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	31.31	20.20	0.00	6.06	2.02	4.04	1.01	0.00	0.00	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	21.08	8.01	2.11	3.79	2.11	1.26	1.26	0.00	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	16.34	5.45	1.36	1.36	1.36	4.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	10.81	11.44	0.00	3.18	3.81	1.91	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	18.63	8.91	0.00	3.24	0.81	2.43	0.81	0.81	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	18.13	7.55	3.02	0.00	0.00	0.00	3.02	0.00	1.51	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	0.00	0.00	0.00	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	13.05	6.52	3.26	3.26	9.79	6.52	0.00	0.00	6.52	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	0.00	4.75	9.50	0.00	0.00	4.75	0.00	4.75	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.53	2.80	5.60	4.52	0.43	1.51	0.65	0.86	1.51	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	60.10	5.23	3.66	2.61	0.52	2.61	0.52	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	53.40	5.34	3.34	1.33	3.34	0.67	0.67	0.67	2.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	31.30	3.34	7.10	1.25	2.50	1.25	0.00	0.83	2.92	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	34.99	6.46	4.56	3.99	3.61	3.23	1.52	2.47	0.38	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	7.98	3.19	6.38	0.00	1.60	0.00	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	29.92	2.72	4.08	0.68	0.00	0.00	2.04	0.00	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	27.56	1.84	5.51	5.51	0.00	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	42.69	2.09	4.19	0.84	0.42	0.42	0.00	0.84	0.84	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	39.51	4.65	5.58	2.56	0.70	1.16	0.93	0.46	2.09	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	39.72	4.05	2.16	1.08	0.00	1.35	1.08	0.54	0.54	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	29.85	6.31	1.89	1.89	1.47	1.05	0.42	0.63	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	0.00	11.13	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	58.07	3.47	3.97	1.49	0.00	0.00	1.99	0.50	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.10	1.08	2.17	3.52	0.00	1.35	0.54	0.81	0.00	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	42.39	3.85	6.35	1.13	0.68	0.68	0.23	0.45	1.36	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	29.23	1.63	2.12	0.49	0.65	0.65	1.14	0.33	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.34	3.65	1.28	1.09	1.46	1.64	1.09	0.73	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	50.92	1.59	5.30	0.53	0.53	0.00	2.12	0.53	1.59	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	37.82	1.80	3.60	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	42.33	2.63	3.61	2.95	1.64	2.63	0.98	2.30	0.00	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.36	4.88	2.93	1.14	0.98	0.81	0.33	0.16	0.81	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	28.04	3.88	1.41	0.88	0.88	0.53	0.35	0.71	0.35	0.35
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	36.57	2.11	2.81	0.70	0.00	0.70	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	33.10	1.38	4.14	0.92	1.84	1.38	0.46	0.00	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.10	2.89	1.93	1.61	0.96	0.64	1.93	0.32	0.32	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	39.32	5.17	3.45	2.41	1.03	2.76	0.69	1.03	0.00	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	5.06	5.06	10.11	0.00	0.00	5.06	10.11	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.16	3.56	0.45	1.78	0.89	1.11	0.22	0.22	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	37.68	2.96	3.81	1.27	0.00	0.85	0.00	0.42	1.27	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.72	3.80	2.61	0.71	0.47	0.95	1.19	0.24	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	47.65	4.29	1.72	0.43	1.72	0.43	0.43	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	45.14	9.03	0.00	36.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	32.32	5.33	1.67	1.00	1.00	0.33	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	18.94	3.61	1.80	0.45	0.00	1.35	0.00	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.41	1.98	0.79	0.79	0.40	0.79	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	43.65	8.36	1.86	0.93	0.93	0.93	0.00	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	42.38	4.16	1.51	2.27	1.14	0.76	1.14	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	34.54	3.91	0.98	2.28	0.98	1.30	0.00	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.99	3.49	2.18	0.44	0.44	1.74	0.00	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	17.64	2.71	2.71	0.00	0.45	0.90	0.45	0.45	0.90	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	37.04	1.76	3.53	2.65	1.76	0.88	0.00	0.88	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	29.92	1.99	0.66	1.33	0.00	1.33	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	51.09	4.46	0.99	0.50	0.00	0.99	0.00	0.50	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	43.26	3.83	3.06	1.53	1.91	1.53	0.00	0.77	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	45.06	5.14	1.81	1.51	1.21	3.63	1.81	0.60	0.00	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.32	1.77	3.54	1.11	0.88	1.33	0.22	0.66	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	35.92	1.36	2.03	0.68	0.68	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	30.66	5.11	0.00	5.11	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	43.29	6.10	2.44	1.22	0.61	0.00	0.00	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	45.64	5.67	2.52	0.31	0.94	1.26	0.00	0.94	0.31	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	40.56	6.66	1.21	1.21	0.91	1.21	0.30	0.61	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	41.14	3.16	2.37	2.37	0.79	0.79	0.00	0.79	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	45.35	3.40	5.67	3.40	0.00	2.27	2.27	2.27	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	5.06	0.00	10.12	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	34.16	2.86	6.34	3.48	0.87	0.62	0.75	1.49	1.74	0.37
Myoblast, donor2	11322-117D8	39.32	4.79	4.22	2.88	1.92	1.53	0.96	0.58	0.96	1.15
Myoblast, donor3	11398-118D3	35.31	3.87	6.22	4.71	0.67	2.02	1.18	1.18	2.35	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	15.18	28.75	2.04	2.48	75.01	4.82	0.44	0.29	0.58	11.82
Natural Killer Cells, donor1	11230-116C6	4.61	28.91	0.92	4.92	59.97	8.30	3.69	1.23	0.62	11.69
Natural Killer Cells, donor2	11311-117C6	5.13	15.38	0.90	1.21	44.03	4.82	1.51	1.81	0.90	6.94
Natural Killer Cells, donor3	11387-118C1	4.97	22.45	1.10	1.47	45.83	5.71	3.31	2.02	0.00	7.73
Neural stem cells, donor1	11275-116H6	70.77	7.26	3.99	5.08	1.81	3.27	1.45	1.09	0.73	0.73
Neural stem cells, donor2	11352-117H2	34.66	11.55	0.00	11.55	1.93	7.70	1.93	3.85	0.00	1.93
Neurons, donor1	11494-119E9	50.07	11.38	1.14	10.24	1.14	6.83	2.28	1.14	1.14	0.00
Neurons, donor2	11574-120E8	55.92	12.33	3.74	12.55	0.22	5.72	2.86	1.54	0.22	0.88
Neurons, donor3	11655-122E8	37.82	9.87	4.93	5.76	4.93	2.47	4.11	3.29	0.82	1.64
Neutrophils, donor1	11233-116C9	8.35	48.26	1.86	3.71	36.19	22.27	13.92	6.50	0.93	12.99
Neutrophils, donor2	11314-117C9	26.09	40.58	2.90	0.00	20.29	20.29	14.49	5.80	0.00	5.80
Neutrophils, donor3	11390-118C4	8.55	87.96	1.22	3.67	47.65	25.04	25.04	9.16	0.00	9.77
Nucleus Pulposus Cell, donor1	11252-116F1	60.32	5.46	4.27	3.21	0.59	0.59	0.36	0.59	0.24	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	59.59	4.23	3.26	0.33	0.65	1.30	0.33	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	41.92	4.41	3.01	0.40	0.60	0.80	1.00	0.20	0.60	0.20
Olfactory epithelial cells, donor1	11933-125I7	25.88	1.79	2.89	0.69	0.55	1.24	0.55	0.28	1.10	0.00
Olfactory epithelial cells, donor2	11934-125I8	38.50	2.75	8.40	1.16	0.14	1.16	0.29	1.30	2.61	0.43
Olfactory epithelial cells, donor3	11935-125I9	35.75	3.97	7.49	1.36	0.79	1.02	0.68	0.57	1.93	0.45
Olfactory epithelial cells, donor4	11936-126A1	40.23	2.34	4.29	2.24	0.78	1.95	0.88	0.58	1.07	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	43.93	6.02	19.26	6.62	0.00	2.41	1.20	2.41	3.01	1.20
Osteoblast - differentiated, donor1	11276-116H7	58.07	3.62	4.89	2.34	0.64	2.34	1.06	0.85	0.64	0.43
Osteoblast - differentiated, donor2	11353-117H3	42.30	4.57	5.72	0.00	1.14	4.57	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	27.93	6.83	3.10	2.48	0.62	1.24	0.62	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	62.93	7.04	10.75	4.89	0.78	2.15	1.17	1.17	2.15	0.39
Osteoblast, donor2	11354-117H4	46.35	5.62	7.02	4.92	0.70	0.70	0.70	1.40	2.11	0.70
Osteoblast, donor3	11426-118G4	42.30	5.69	5.33	2.84	0.18	2.49	1.42	2.13	2.13	0.18
Pancreatic stromal cells, donor1	11249-116E7	45.49	5.39	4.30	3.79	0.67	2.44	1.10	0.76	0.67	0.51
Pericytes, donor1	11491-119E6	84.01	15.13	5.79	7.12	1.22	2.67	1.00	1.67	0.45	1.89
Pericytes, donor2	11571-120E5	57.72	17.20	2.94	5.89	0.68	1.36	0.68	1.13	0.45	2.04
Pericytes, donor3	11652-122E5	48.62	5.09	8.54	3.05	1.83	3.26	0.61	0.81	1.22	0.20
Perineurial Cells, donor1	11499-119F5	46.68	4.29	4.29	4.41	0.57	1.58	0.68	0.34	0.68	0.45
Perineurial Cells, donor2	11579-120F4	38.83	5.24	6.81	2.67	0.37	2.12	1.56	0.37	1.47	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	14.02	32.51	1.27	1.59	24.54	6.06	3.19	1.91	0.96	7.65
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.30	14.20	0.73	1.22	15.92	4.16	1.47	0.98	0.24	3.92
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	8.54	23.55	0.78	1.94	23.04	5.18	1.55	1.55	0.26	5.05
Placental Epithelial Cells, donor1	11278-116H9	69.60	17.22	31.57	10.04	2.87	6.70	4.30	5.02	10.76	0.24
Placental Epithelial Cells, donor2	11355-117H5	67.64	12.20	16.63	13.31	2.22	3.33	2.22	1.11	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	49.28	7.66	17.67	5.89	0.39	2.36	0.39	0.98	4.32	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	30.70	2.53	6.96	2.53	0.32	0.63	0.32	0.95	1.90	0.63
Preadipocyte - breast, donor1	11467-119B9	42.39	4.31	5.63	2.81	0.19	1.13	1.13	0.19	1.31	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	13.31	4.57	1.57	2.74	0.13	1.04	0.91	0.91	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	37.15	4.28	3.83	0.90	0.68	0.68	0.23	1.35	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	59.78	3.41	8.42	3.62	0.64	1.70	0.53	0.85	1.92	0.43
Preadipocyte - omental, donor2	11329-117E6	41.03	4.36	3.49	1.75	0.44	1.31	1.31	1.31	1.31	0.44
Preadipocyte - omental, donor3	11403-118D8	43.83	6.88	5.73	3.72	0.57	1.72	0.29	1.00	1.43	0.43
Preadipocyte - perirenal, donor1	11469-119C2	44.29	4.92	5.91	4.92	1.97	0.00	1.97	0.98	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	52.52	6.14	7.68	2.15	0.31	1.23	0.61	0.31	3.07	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	38.96	3.36	5.84	3.54	0.71	1.95	1.42	1.42	1.06	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	35.42	5.62	3.41	2.89	0.85	1.53	0.68	0.85	0.68	0.34
Preadipocyte - visceral, donor1	11280-116I2	48.81	5.78	4.84	5.31	0.56	1.40	1.30	1.49	0.93	0.37
Preadipocyte - visceral, donor2	11357-117H7	28.99	1.84	4.14	2.30	0.00	0.92	0.46	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	35.84	4.39	4.08	2.51	0.84	0.63	0.73	0.31	0.73	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	16.44	4.83	9.20	3.92	0.75	1.66	1.06	0.75	2.41	0.30
Prostate Epithelial Cells, donor2	11331-117E8	55.38	5.01	14.35	3.52	1.49	2.71	0.95	1.22	5.01	0.68
Prostate Epithelial Cells, donor3	11404-118D9	40.48	7.65	15.13	6.12	1.90	3.67	0.73	1.59	1.78	0.55
Prostate Stromal Cells, donor1	11254-116F3	53.08	3.87	6.83	2.62	0.34	2.62	1.14	0.91	1.14	0.68
Prostate Stromal Cells, donor2	11332-117E9	51.10	4.66	2.51	2.51	0.90	1.97	1.26	0.54	1.26	0.18
Prostate Stromal Cells, donor3	11405-118E1	45.15	4.28	4.07	3.13	0.10	0.94	0.94	1.04	0.94	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	35.04	5.84	15.33	12.77	0.00	2.55	0.36	3.65	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	32.65	2.63	10.67	4.51	0.28	1.39	0.83	0.90	0.90	0.14
Renal Epithelial Cells, donor1	11517-119H5	52.75	13.70	20.29	10.14	0.00	5.07	1.52	3.55	3.55	0.00
Renal Epithelial Cells, donor2	11597-120H4	39.83	3.56	15.65	3.56	0.00	2.85	0.71	2.85	2.85	0.00
Renal Epithelial Cells, donor3	11678-122H4	35.57	1.91	7.94	5.50	0.53	1.38	0.64	0.74	0.42	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	40.85	8.85	6.13	0.68	0.68	2.04	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	45.95	7.28	7.41	3.50	0.67	1.08	0.81	1.35	1.75	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	33.52	6.66	7.99	2.00	0.22	2.22	0.44	0.22	1.11	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	59.22	5.32	3.99	2.66	0.00	4.66	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	64.93	9.90	11.88	7.70	0.22	1.98	1.32	1.32	2.42	0.00
Renal Mesangial Cells, donor2	11598-120H5	44.52	5.64	8.15	11.29	0.63	1.88	0.00	0.63	3.76	0.00
Renal Mesangial Cells, donor3	11679-122H5	52.15	6.10	9.71	6.38	0.00	0.83	1.39	2.77	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	42.14	9.93	19.33	9.66	0.81	1.88	1.61	1.61	5.10	0.54
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	40.90	6.33	18.55	3.80	0.84	1.69	0.84	1.69	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	39.34	5.01	13.31	8.49	0.39	2.89	1.54	0.96	1.35	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	43.30	8.56	7.52	9.33	0.26	2.85	3.11	3.11	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	40.65	7.67	6.25	3.70	0.85	2.56	1.14	0.28	0.57	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	38.08	4.12	4.12	8.23	1.03	4.12	1.03	0.00	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	35.13	3.76	5.02	3.01	1.00	1.76	1.00	0.25	1.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	71.90	11.76	12.43	15.64	2.27	4.94	3.07	5.21	1.20	1.47
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	3.57	6.25	0.00	7.15	1.79	0.00	0.00	0.89	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	52.84	14.86	25.32	4.40	4.95	2.75	1.10	0.55	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.12	7.54	12.76	1.16	2.32	1.16	0.00	0.58	2.32	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	28.48	8.58	4.94	2.34	2.08	1.82	0.26	0.39	1.04	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	27.51	6.95	6.16	2.78	1.99	1.89	0.20	0.50	0.60	0.79
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	29.45	8.14	7.92	3.12	2.01	0.78	0.89	0.45	1.45	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	36.22	8.43	7.44	7.32	1.74	1.49	0.50	1.24	0.74	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	31.47	8.86	5.71	3.85	1.40	0.93	0.47	0.70	0.58	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	35.36	6.24	3.47	3.70	3.47	0.69	0.46	0.23	0.69	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	32.04	7.80	5.75	2.88	1.64	1.92	0.41	0.68	1.10	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	29.35	5.75	6.20	3.18	1.82	0.61	0.61	0.91	0.76	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	36.55	6.27	7.17	3.94	3.05	1.79	0.54	0.18	0.90	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	34.86	11.05	6.31	4.45	2.15	1.72	0.29	1.00	0.72	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.37	7.19	5.37	3.33	1.50	1.18	0.43	0.54	0.64	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	34.74	10.18	4.65	3.76	1.77	1.33	0.22	0.22	0.89	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	29.82	8.60	6.69	4.59	1.72	0.96	0.96	0.38	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	28.14	6.99	4.66	3.26	2.14	1.02	0.19	0.37	1.21	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	37.96	4.51	8.83	3.19	2.63	0.38	0.19	0.56	1.32	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	28.93	12.34	4.38	3.05	1.99	1.06	0.27	0.53	0.13	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	23.85	7.50	5.26	3.02	2.24	1.46	0.29	0.68	0.68	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	29.60	7.64	4.77	3.25	2.67	1.91	0.76	0.57	0.38	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	29.26	8.65	5.98	3.42	0.96	1.39	0.53	0.96	0.64	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	23.83	9.25	5.61	5.61	1.12	1.12	0.28	0.28	0.84	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	26.49	9.06	5.98	2.39	1.20	1.20	0.34	0.68	1.54	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.80	9.85	6.20	2.92	1.82	0.91	0.36	0.55	0.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	30.17	10.91	6.74	3.07	1.59	0.86	0.74	0.25	0.49	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	29.42	6.31	5.64	3.36	1.75	1.07	0.00	0.40	0.94	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	41.04	9.20	6.84	6.60	1.89	0.47	0.71	0.24	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	27.18	8.73	7.54	2.38	3.37	0.99	0.40	0.79	0.79	1.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	31.34	9.35	5.61	1.87	1.64	1.40	0.00	0.94	0.94	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	35.25	9.75	6.64	2.70	2.49	1.24	0.41	1.04	0.83	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	26.55	7.52	3.98	2.21	1.33	0.66	0.44	0.88	1.77	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	29.45	7.31	4.80	2.72	2.30	0.42	0.84	0.42	1.67	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	32.03	9.96	5.11	4.31	1.62	1.88	0.40	0.40	0.94	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	23.33	8.86	4.94	1.87	1.87	1.53	0.00	0.85	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	25.64	7.52	4.43	2.31	2.12	1.16	0.39	0.77	0.96	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	35.59	9.97	8.25	6.53	1.03	1.72	0.86	0.69	0.69	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	20.16	8.78	5.49	2.88	1.10	1.37	0.69	0.41	1.10	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.27	5.58	6.07	4.27	0.99	0.66	0.33	0.49	0.99	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	29.14	9.03	7.84	5.28	1.02	1.02	0.00	0.00	1.36	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	27.22	7.84	7.25	3.40	1.63	0.44	0.44	0.59	1.04	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.06	4.53	4.26	4.53	3.73	2.13	0.00	0.53	1.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	21.29	10.09	4.84	4.70	2.49	1.52	0.14	0.55	0.28	0.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	22.14	6.19	4.29	3.33	1.67	0.95	0.00	0.48	0.24	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	30.84	8.26	8.06	4.23	1.41	1.41	0.00	0.81	0.60	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	34.56	10.55	8.38	5.18	1.51	1.04	0.75	0.75	1.13	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	31.79	12.23	8.73	2.45	3.84	0.35	0.35	1.05	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	16.62	7.86	3.02	1.81	2.42	1.81	0.60	0.60	0.91	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	54.09	9.42	11.63	3.06	1.71	1.84	0.61	1.35	0.98	1.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	29.98	11.79	9.32	3.35	3.49	1.31	0.15	0.15	1.31	1.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	26.77	10.34	7.30	3.04	3.65	1.22	0.61	0.00	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	43.70	9.95	15.37	3.32	2.11	3.01	1.21	0.60	1.51	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	47.05	14.25	14.02	3.17	3.17	1.81	0.90	1.13	2.04	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	43.43	12.88	15.58	5.99	3.89	2.10	0.30	1.50	3.00	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	51.83	14.29	15.82	5.67	3.90	3.07	1.18	0.83	3.19	2.01
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	33.94	13.02	12.81	3.84	2.56	0.85	0.43	0.21	1.07	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	34.26	3.61	10.22	1.20	4.21	1.20	0.60	1.20	1.80	1.20
Schwann Cells, donor1	11498-119F4	42.13	7.52	4.70	6.21	0.19	2.63	1.88	1.13	0.19	0.94
Schwann Cells, donor2	11578-120F3	13.61	0.00	3.40	0.00	3.40	10.21	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	48.20	4.60	5.48	3.07	0.66	1.31	1.10	0.44	0.22	0.22
Sebocyte, donor1	11220-116B5	77.24	8.76	21.91	8.22	1.10	0.55	1.10	0.55	4.38	1.10
Sebocyte, donor2	11301-117B5	58.36	6.43	24.82	5.51	0.92	2.76	0.46	0.46	6.43	0.00
Sebocyte, donor3	11378-118B1	61.42	6.39	18.96	5.15	1.03	2.47	0.21	1.44	3.50	0.62
Sertoli Cells, donor1	11255-116F4	61.29	3.31	13.25	3.31	1.66	3.31	0.00	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	62.14	8.47	2.82	5.65	2.82	0.00	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	61.76	8.01	5.37	5.72	1.41	2.82	1.41	1.14	0.35	0.79
Skeletal Muscle Cells, donor2	11358-117H8	32.53	5.06	1.45	1.45	0.00	1.45	0.00	1.45	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	47.65	10.03	6.69	4.18	1.67	2.51	0.84	2.51	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	33.93	6.28	4.71	5.03	0.31	1.73	1.57	1.10	0.47	0.79
Skeletal Muscle Cells, donor5	11455-119A6	32.26	3.57	5.35	3.42	0.45	1.04	1.04	0.89	0.89	0.59
Skeletal Muscle Cells, donor6	11459-119B1	24.78	5.54	3.23	5.08	0.15	2.77	1.08	1.08	0.62	0.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	56.07	5.92	5.54	3.91	0.25	2.52	0.63	1.13	0.38	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	45.37	4.28	4.14	0.86	0.43	1.28	1.00	0.86	0.57	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	32.14	5.95	4.46	4.27	0.30	1.59	0.89	1.59	0.50	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	42.38	5.64	3.03	3.20	0.42	1.26	0.59	0.93	1.18	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	39.08	5.79	5.07	4.34	0.72	1.45	1.45	0.72	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	36.46	5.92	6.19	1.93	0.41	0.69	0.55	0.69	0.96	0.41
Skin - palm, donor1	10286-104F7	10.74	5.37	2.69	5.37	0.00	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	58.24	8.79	21.77	5.05	1.15	2.59	1.15	1.15	7.78	0.72
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	51.53	11.45	22.90	9.81	2.45	9.00	4.09	0.00	6.54	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	51.80	5.45	29.47	2.86	1.30	2.34	0.52	1.56	7.14	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	50.46	6.26	18.21	4.17	1.11	1.53	0.97	1.39	4.59	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	32.63	7.88	18.57	2.81	0.56	1.13	0.70	0.70	4.78	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	40.60	14.80	18.40	9.73	2.11	4.44	2.75	2.75	4.44	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	38.82	11.24	14.02	2.85	1.12	3.37	0.30	0.75	3.22	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	68.51	2.78	12.34	2.47	0.31	1.54	0.62	0.00	2.78	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	47.13	5.11	5.11	5.78	0.67	1.33	0.67	1.56	0.44	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.09	4.70	8.82	4.11	0.00	4.11	2.35	0.59	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	39.78	5.30	5.75	1.33	0.88	1.33	0.88	0.44	0.88	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	49.22	5.51	11.42	4.33	0.79	2.36	0.79	0.39	2.76	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	36.31	2.32	3.09	3.09	0.00	1.55	0.00	1.55	0.77	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	52.04	7.01	1.00	4.00	0.00	0.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	46.44	2.53	9.05	3.19	0.53	2.00	0.93	0.53	2.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	55.19	6.65	7.31	2.88	0.89	1.55	0.66	1.55	1.11	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	37.00	4.48	6.91	1.79	0.26	1.66	0.51	0.64	2.43	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	29.30	3.58	3.58	1.63	0.65	0.98	1.30	0.33	0.98	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	28.35	3.54	4.13	1.77	0.59	2.95	1.48	0.59	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.21	2.56	3.13	1.42	0.43	1.28	0.43	0.57	1.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	45.87	4.88	5.37	6.67	0.00	3.42	1.14	2.11	0.49	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	29.53	6.39	0.91	0.91	0.91	3.04	0.61	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	43.19	5.05	3.28	3.79	0.76	2.27	1.01	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	0.00	6.12	6.12	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	33.38	4.77	4.77	1.43	0.00	0.48	0.00	0.00	0.48	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.17	3.69	3.83	1.77	0.15	1.03	0.59	0.59	0.74	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	31.86	3.01	5.60	1.08	0.22	1.51	0.43	0.65	1.51	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	31.70	3.67	3.36	2.62	0.73	1.26	0.73	0.31	0.42	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.97	3.71	11.60	4.02	0.93	2.47	1.39	1.55	3.40	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	72.22	3.23	14.01	0.00	1.08	2.16	2.16	1.08	6.47	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.59	2.69	6.57	2.09	0.30	0.90	0.90	0.30	1.20	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	42.33	6.49	6.49	6.83	0.68	2.05	2.05	0.68	1.02	1.02
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.97	3.93	4.87	1.33	0.71	1.41	0.47	0.47	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	80.41	3.62	14.29	2.11	0.40	2.01	1.11	1.01	3.72	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	34.59	2.50	2.50	2.96	0.23	2.50	0.46	0.23	2.05	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	44.08	3.62	6.04	3.62	0.00	0.00	0.00	0.60	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	32.85	6.09	6.62	4.77	0.26	1.06	1.06	3.44	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	47.94	7.72	6.26	2.66	0.93	1.46	1.07	0.67	1.20	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.72	3.88	4.76	1.63	1.13	1.25	1.63	0.75	0.75	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	35.01	4.31	1.01	1.52	0.51	1.52	1.01	0.51	1.01	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	55.18	3.92	9.20	3.32	0.90	1.21	0.75	0.90	2.11	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	42.76	3.00	5.25	4.50	0.00	2.25	1.50	1.50	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	62.03	7.75	10.34	7.75	1.29	1.29	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	71.16	3.72	6.51	2.33	0.47	2.79	0.47	0.93	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	61.09	4.54	10.60	0.50	0.00	2.52	2.02	0.50	3.53	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.52	4.39	11.28	1.25	0.94	2.19	0.94	0.63	2.51	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	53.10	2.95	6.49	4.42	0.29	1.77	0.59	0.29	2.36	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	38.57	7.33	5.08	5.08	0.58	2.25	1.50	1.25	0.92	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	38.77	6.54	4.20	1.40	0.00	0.93	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	50.08	4.61	8.06	2.73	1.30	1.87	0.86	0.58	3.17	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	46.40	4.33	6.37	3.31	1.02	2.04	1.78	1.02	0.51	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	34.03	3.95	3.95	1.50	0.94	1.88	0.75	0.38	1.69	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	30.88	5.45	4.05	5.87	0.00	2.10	0.98	0.28	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.38	2.43	4.61	2.35	0.34	0.67	0.67	0.42	0.34	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	33.33	7.62	3.81	6.67	0.00	3.33	1.43	1.43	0.95	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	45.51	2.69	10.77	2.20	0.49	2.94	0.73	0.98	2.69	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	42.20	2.43	7.29	1.77	0.44	0.88	0.66	0.44	1.55	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	40.08	7.90	5.85	5.27	0.59	1.46	1.17	1.17	0.59	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	48.20	4.47	2.33	1.55	0.97	2.14	1.36	0.78	0.19	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.23	2.64	6.35	1.85	0.53	2.12	0.79	0.26	2.38	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	65.09	4.46	5.95	4.09	2.23	4.09	1.12	0.74	0.74	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	51.03	3.59	5.75	1.80	0.00	1.44	1.80	1.08	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.96	4.26	6.81	3.12	0.28	3.69	0.28	1.42	1.70	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	31.51	4.73	6.30	1.58	0.00	2.76	1.58	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	38.09	3.81	4.57	2.29	0.76	2.03	0.00	0.51	0.00	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	47.12	3.59	2.80	0.80	0.80	0.80	1.20	0.80	0.80	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	34.28	4.18	3.34	2.51	0.84	0.84	0.00	0.84	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	43.09	5.04	1.83	0.92	0.46	1.83	0.46	0.00	0.00	0.46
Synoviocyte, donor1	11291-117A4	31.14	2.19	2.52	1.68	0.84	1.18	0.50	0.67	0.50	0.00
Synoviocyte, donor2	11368-117I9	38.89	3.69	2.01	0.84	0.34	1.84	0.67	0.50	0.67	0.17
Synoviocyte, donor3	11440-118H9	35.97	5.59	1.12	1.12	0.45	1.12	0.89	0.45	0.00	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	55.74	10.01	7.86	10.01	0.71	7.50	3.57	1.07	1.79	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	57.48	7.93	7.93	3.96	0.00	5.95	3.96	1.98	3.96	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	43.07	8.80	3.94	4.17	0.46	1.85	3.24	1.16	0.46	0.46
Tracheal Epithelial Cells, donor1	11292-117A5	39.71	6.59	14.84	4.59	0.50	1.65	0.72	1.00	2.08	0.43
Tracheal Epithelial Cells, donor2	11369-118A1	44.45	7.34	15.85	2.71	0.77	2.71	0.39	0.77	2.32	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	36.08	6.87	18.33	1.72	0.57	0.57	0.57	0.57	2.29	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	68.28	12.67	12.30	14.89	3.57	5.54	2.95	2.46	1.85	1.60
Urethra, donor2	10319-105A4	46.76	1.80	3.60	12.59	1.80	1.80	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	45.16	6.64	13.28	7.17	0.27	1.33	0.80	0.53	7.97	0.00
Urothelial Cells, donor2	11600-120H7	42.46	2.40	20.03	7.61	1.20	2.40	0.00	2.80	2.00	0.40
Urothelial Cells, donor3	11681-122H7	42.40	5.73	19.48	5.04	1.15	1.60	1.15	0.92	4.13	0.00
Urothelial cells, donor0	11216-116B1	34.55	4.68	15.60	4.68	0.22	2.01	0.45	1.34	1.34	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	21.35	63.17	1.78	10.68	25.80	15.13	12.46	3.56	0.89	12.46
Whole blood (ribopure), donor090309, donation2	12180-129A2	22.87	71.48	1.43	4.29	24.30	18.58	7.15	4.29	0.00	11.44
Whole blood (ribopure), donor090309, donation3	12181-129A3	7.53	34.91	1.37	3.42	21.22	11.64	6.85	4.79	0.00	6.85
Whole blood (ribopure), donor090325, donation1	12176-128I7	10.67	27.89	1.03	4.48	30.99	10.33	8.95	1.38	0.00	11.02
Whole blood (ribopure), donor090325, donation2	12177-128I8	13.94	30.79	1.74	2.32	33.12	8.72	9.88	1.74	0.00	9.88
Whole blood (ribopure), donor090612, donation1	12182-129A4	17.70	54.14	2.08	5.21	16.66	14.58	9.37	4.16	2.08	12.49
Whole blood (ribopure), donor090612, donation2	12183-129A5	16.52	47.73	0.00	4.59	26.62	9.18	11.93	1.84	0.00	6.42
Whole blood (ribopure), donor090612, donation3	12184-129A6	7.30	33.78	0.91	4.56	21.00	5.48	7.30	2.74	1.83	7.30
Wilms' tumor cell line:G-401	10809-111A8	39.35	5.55	36.02	2.96	0.37	3.82	2.22	0.99	12.09	0.12
Wilms' tumor cell line:HFWT	10597-108E3	22.88	10.56	6.16	2.64	1.76	0.88	0.88	0.00	0.88	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	52.79	17.60	7.82	7.26	2.23	3.63	1.12	1.40	0.84	0.28
achilles tendon, donor2	10292-104G4	6.20	6.20	2.07	2.07	0.00	2.07	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.10	6.37	0.00	4.08	4.33	1.02	2.04	0.25	0.00	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	22.29	23.68	1.86	8.36	15.79	3.95	3.71	0.70	0.00	3.25
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	26.71	35.73	1.90	3.68	16.86	4.75	1.90	0.95	0.12	8.31
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	95.51	20.68	16.05	6.80	18.23	4.35	1.09	2.45	2.99	7.89
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	18.83	7.87	2.25	1.41	10.68	1.97	0.28	0.00	0.28	2.25
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	61.33	10.36	13.11	7.19	8.25	3.38	1.27	1.06	1.69	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	34.84	7.35	9.26	3.54	19.87	1.63	0.54	0.00	2.72	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	19.39	6.61	3.97	3.53	3.08	1.32	0.00	0.00	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	41.24	7.76	2.86	0.41	6.94	1.63	1.23	0.00	1.23	2.04
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	20.19	23.69	3.49	1.16	17.86	3.11	1.55	0.00	0.39	5.05
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	25.58	6.81	2.76	2.21	6.62	1.66	1.84	0.92	0.92	1.29
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	7.80	3.90	3.90	19.50	7.80	0.00	0.00	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	49.96	6.04	19.52	2.79	2.09	3.95	1.86	0.46	6.04	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	46.34	17.35	5.95	7.25	11.65	4.40	2.85	1.04	0.26	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	34.48	13.74	2.92	3.51	7.89	2.63	0.58	0.58	0.88	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	28.82	17.66	2.32	1.39	14.87	1.39	0.46	1.86	1.39	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	41.54	10.69	3.29	4.52	21.80	3.29	0.41	0.41	0.41	2.47
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	58.01	12.28	3.99	1.53	3.38	3.07	1.23	0.31	1.23	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.12	11.95	5.12	2.99	7.25	3.84	0.43	1.71	1.28	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	45.49	7.89	7.28	3.34	6.67	0.30	1.82	0.30	0.91	1.21
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	40.92	10.11	4.57	3.85	3.85	2.89	1.68	0.96	1.68	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.41	16.04	4.01	1.56	16.93	4.45	2.23	0.89	0.45	3.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	15.68	7.67	2.00	4.34	1.00	2.67	2.00	0.33	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	5.57	3.72	3.72	0.00	0.00	0.00	0.00	3.72	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	38.80	7.53	6.03	1.13	9.42	1.51	0.00	0.75	1.13	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	54.08	8.72	22.68	3.05	15.26	6.11	2.18	0.44	8.29	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	13.12	16.87	5.62	1.87	0.00	5.62	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	47.57	18.84	7.30	7.77	0.94	2.35	0.24	2.59	0.94	0.24
adipose tissue, adult, pool1	10010-101C1	39.40	4.65	3.10	4.96	1.09	2.17	0.78	1.71	0.78	0.16
adipose, donor1	10184-103D4	28.15	9.97	8.21	85.62	0.00	5.28	2.35	7.62	0.00	0.00
adipose, donor2	10185-103D5	56.37	12.17	5.27	11.76	1.62	2.43	1.22	1.22	0.41	2.03
adipose, donor3	10186-103D6	36.49	11.98	4.63	14.16	0.82	2.72	1.09	1.36	0.27	0.27
adipose, donor4	10187-103D7	36.40	7.80	12.13	22.54	1.73	0.87	3.47	2.60	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	33.62	5.37	4.42	3.31	0.16	2.05	0.47	0.16	0.95	0.47
adrenal gland, adult, pool1	10081-102A9	50.93	3.64	0.00	3.64	0.00	0.00	3.64	0.00	0.00	7.28
adult T-cell leukemia cell line:ATN-1	10421-106C7	81.51	15.48	9.87	18.94	27.48	6.00	4.94	8.67	1.07	10.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	66.10	15.72	5.72	2.50	2.14	3.93	2.86	0.71	0.71	2.86
amniotic membrane cells, donor1	12235-129G3	48.22	7.19	16.69	15.77	2.78	2.55	1.62	5.56	3.25	1.39
amniotic membrane cells, donor2	12236-129G4	44.97	8.45	11.50	11.83	3.04	3.72	1.69	3.72	0.00	1.69
amniotic membrane cells, donor3	12237-129G5	48.90	7.37	10.31	14.73	1.18	0.88	0.88	4.71	0.59	0.88
amygdala - adult, donor10196	10167-103B5	71.15	13.04	7.11	5.93	1.19	4.74	3.56	2.37	1.19	1.19
amygdala, adult, donor10252	10151-102I7	61.03	12.77	2.23	15.00	0.41	4.46	3.24	3.45	0.00	1.01
amygdala, newborn, donor10223	10360-105E9	55.52	6.46	6.13	2.90	1.29	5.16	2.26	1.29	1.29	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	40.24	4.58	2.29	1.53	0.76	2.93	0.89	0.00	0.13	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	19.64	10.59	3.09	5.52	5.96	2.43	0.88	3.09	1.32	1.54
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	30.73	7.35	3.34	4.01	0.33	4.01	1.67	0.33	0.33	0.67
aorta, adult, pool1	10052-101G7	40.60	8.43	3.14	3.33	1.18	1.57	0.98	0.98	0.78	0.59
appendix, adult	10189-103D9	40.36	19.41	4.66	6.99	15.52	6.21	3.49	3.10	1.16	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	37.49	10.32	11.01	19.95	0.34	1.72	0.00	1.03	0.69	0.69
artery, adult	10190-103E1	36.68	2.72	2.72	10.87	0.00	6.79	2.72	6.79	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	135.16	14.34	15.65	5.65	0.43	5.79	2.75	0.87	1.30	1.45
b cell line:RPMI1788	10427-106D4	22.90	32.12	0.74	4.16	16.36	5.65	1.34	1.78	0.00	8.62
basal cell carcinoma cell line:TE 354.T	10702-109G9	12.49	6.66	2.50	1.66	1.39	0.55	0.28	0.55	0.83	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	26.20	9.23	13.30	11.51	1.29	3.87	1.19	2.08	2.28	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	25.11	12.05	2.18	2.85	1.67	3.18	1.17	1.00	0.33	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	37.47	26.84	3.36	0.56	22.93	5.03	0.56	0.00	1.12	5.03
bladder, adult, pool1	10011-101C2	74.42	6.41	9.13	8.04	1.30	2.61	2.50	3.48	1.41	0.65
blood, adult, pool1	10053-101G8	13.29	28.79	0.00	0.00	24.36	11.07	0.00	0.00	0.00	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	3.43	3.43	4.28	2.57	0.86	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	46.56	3.37	0.67	3.37	0.00	1.35	2.02	0.67	0.67	1.35
brain, adult, donor1	10084-102B3	82.01	20.50	5.13	7.18	2.05	12.30	3.08	0.00	2.05	1.03
brain, adult, pool1	10012-101C3	84.74	20.04	4.57	12.92	0.78	6.24	3.67	2.78	0.56	1.45
brain, fetal, pool1	10085-102B4	74.80	18.70	0.00	2.67	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	31.38	11.56	9.25	3.96	1.32	0.66	1.32	1.65	0.99	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	42.94	3.00	4.62	10.98	1.25	1.62	0.75	2.75	0.62	1.00
breast, adult, donor1	10080-102A8	39.78	5.68	5.68	7.58	0.63	5.05	2.53	2.53	0.63	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.29	9.53	12.07	1.40	0.64	1.02	1.14	1.02	1.78	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	21.34	7.73	4.95	0.93	0.62	0.31	0.62	0.31	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	59.17	5.06	6.68	5.30	0.69	2.76	0.92	0.69	0.69	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	41.15	8.96	11.62	3.39	1.21	2.18	1.21	0.48	2.91	1.21
carcinoid cell line:NCI-H1770	10703-109H1	58.30	3.29	11.75	9.87	0.00	3.29	2.35	1.41	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	28.33	13.34	7.00	4.38	0.88	4.70	2.19	0.77	1.42	0.66
carcinoid cell line:SK-PN-DW	10719-109I8	35.81	3.49	10.77	2.85	0.00	2.22	0.00	0.00	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	88.10	13.84	7.99	6.39	1.33	8.78	7.19	2.13	0.80	2.13
caudate nucleus - adult, donor10196	10177-103C6	82.90	21.88	1.15	9.21	1.15	11.51	0.00	2.30	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	45.18	12.38	3.68	14.56	1.51	8.53	2.51	3.35	0.67	0.84
caudate nucleus, adult, donor10258	10379-105H1	71.06	12.99	6.11	9.17	0.00	7.64	6.88	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	74.35	5.49	7.32	4.76	0.73	4.03	2.20	1.10	1.83	0.37
cerebellum - adult, donor10196	10173-103C2	55.35	32.05	2.91	20.39	0.00	8.74	5.83	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	45.48	11.53	1.07	33.09	0.43	6.83	4.06	5.98	0.21	0.21
cerebellum, adult, pool1	10083-102B2	42.43	16.56	3.79	10.69	0.34	5.17	2.76	1.38	0.69	0.34
cerebellum, newborn, donor10223	10357-105E6	73.90	13.28	4.98	20.76	0.00	4.98	2.49	2.49	0.00	0.83
cerebral meninges, adult	10188-103D8	58.50	11.09	6.56	6.81	0.50	6.30	2.77	3.03	0.25	0.76
cerebrospinal fluid, donor2	10294-104G6	21.93	8.77	2.92	11.69	1.46	0.73	1.46	1.46	1.46	0.00
cervical cancer cell line:D98-AH2	10552-107I3	60.53	11.79	25.45	16.97	1.58	4.89	2.30	3.31	1.29	1.73
cervical cancer cell line:ME-180	10553-107I4	62.81	9.78	49.05	6.13	1.16	4.14	1.99	0.50	5.97	0.00
cervix, adult, pool1	10013-101C4	81.05	9.97	7.98	9.45	1.68	3.36	3.46	3.25	1.15	1.05
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	72.32	13.24	7.38	5.99	4.18	8.92	2.65	2.51	0.84	1.95
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	3.92	1.31	3.92	1.31	1.31	1.31	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	66.61	11.18	20.75	10.19	1.49	2.49	2.49	0.99	1.62	1.24
choriocarcinoma cell line:SCH	10785-110H2	49.53	12.44	6.16	2.83	0.25	4.81	1.23	0.49	0.99	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	44.83	11.86	7.35	11.15	1.19	2.37	2.85	0.71	0.47	0.47
chorionic membrane cells, donor1	12238-129G6	65.53	12.54	23.93	9.69	3.42	3.70	1.71	1.99	5.41	0.57
chorionic membrane cells, donor2	12239-129G7	48.22	6.66	16.21	9.15	2.09	3.48	0.50	2.19	3.78	0.70
chorionic membrane cells, donor3	12240-129G8	71.43	15.94	37.91	6.59	0.55	3.30	0.55	1.65	4.95	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	37.36	13.13	5.05	26.25	8.08	3.03	0.00	6.06	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	8.64	7.88	1.54	0.58	4.80	1.15	0.38	0.19	0.38	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	22.17	7.39	2.11	1.27	5.91	1.48	0.63	0.42	0.42	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	22.34	3.60	2.31	8.73	1.80	0.26	0.26	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	23.95	1.21	2.66	9.92	0.24	1.69	0.97	0.97	0.24	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	20.36	2.65	4.28	10.38	1.63	1.43	0.81	1.43	0.61	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	19.73	2.06	1.18	10.89	2.06	0.29	1.18	0.29	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	50.82	9.38	4.43	3.91	5.99	3.13	1.04	2.35	0.52	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	25.37	5.49	5.94	8.00	0.23	1.37	0.69	0.46	0.23	0.00
clear cell carcinoma cell line:TEN	10636-108I6	27.59	8.33	4.16	3.47	1.04	2.26	1.21	1.21	0.35	0.69
colon carcinoma cell line:CACO-2	10513-107D9	26.54	6.22	10.98	5.86	0.55	1.28	0.92	0.37	1.65	0.55
colon carcinoma cell line:COLO-320	10420-106C6	53.21	7.22	15.96	6.08	0.76	1.52	0.76	1.52	0.38	0.38
colon, adult, donor1	10082-102B1	73.78	8.33	21.42	5.95	5.95	1.19	0.00	1.19	2.38	0.00
colon, adult, pool1	10014-101C5	71.44	10.58	8.11	11.28	4.47	4.58	2.59	3.88	1.76	2.23
colon, fetal, donor1	10070-101I7	82.19	7.42	16.69	5.56	6.80	3.09	0.62	1.24	2.47	3.09
common myeloid progenitor CMP, donor1	12130-128D6	36.67	9.17	4.58	9.17	13.75	0.00	0.00	0.00	0.00	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	30.17	14.87	5.10	2.12	23.37	8.50	2.12	0.85	2.55	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	59.32	17.96	3.02	1.66	23.09	4.38	1.21	1.36	0.75	4.83
cord blood derived cell line:COBL-a untreated	10449-106F8	62.33	17.49	4.94	2.12	24.68	3.67	1.27	0.99	0.85	6.06
corpus callosum, adult, pool1	10042-101F6	94.53	32.28	3.65	30.29	1.33	9.84	6.52	10.06	0.33	1.22
cruciate ligament, donor2	10295-104G7	21.88	6.48	2.43	2.43	2.43	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.87	4.01	4.01	4.82	0.00	0.80	1.61	2.41	0.00	0.80
diencephalon, adult	10193-103E4	47.76	18.24	3.60	13.92	0.48	5.52	2.40	2.64	0.96	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	4.82	16.30	0.00	3.21	14.24	3.44	2.07	1.15	0.23	3.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.54	8.46	25.13	3.33	0.77	2.56	2.05	0.77	2.56	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	24.07	2.89	19.74	2.89	0.48	2.41	0.96	0.96	1.69	0.24
ductus deferens, adult	10196-103E7	84.72	12.46	5.48	16.94	0.50	2.99	1.99	3.49	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	57.61	7.20	4.32	7.20	11.52	5.76	0.00	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	61.79	8.09	6.62	14.71	2.94	3.68	2.94	3.68	1.47	1.47
dura mater, adult, donor1	10041-101F5	39.23	8.92	3.39	2.56	2.23	2.23	0.91	1.07	0.25	0.83
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	131.69	29.31	50.85	15.32	20.87	27.98	10.44	9.10	6.66	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	86.41	17.77	17.77	25.51	3.15	12.47	7.74	10.32	3.58	1.86
embryonic pancreas cell line:1B2C6	10604-108F1	17.27	9.87	2.47	0.00	0.00	0.62	0.62	0.00	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	22.70	6.66	0.61	0.61	1.21	1.51	0.30	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.93	13.58	1.85	1.23	0.93	1.54	0.93	0.00	0.00	0.93
embryonic pancreas cell line:2C6	10603-108E9	21.02	7.88	2.63	1.31	2.63	2.63	1.31	0.00	1.31	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	36.54	3.69	12.07	19.44	1.68	1.01	1.34	5.70	1.68	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	70.50	12.32	19.21	1.99	2.54	2.72	1.09	0.36	3.62	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	51.94	5.15	15.60	4.02	3.38	2.09	0.80	1.29	2.73	0.80
epidermoid carcinoma cell line:A431	10426-106D3	39.13	5.56	18.56	3.45	0.89	1.45	0.78	1.11	2.89	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	49.38	6.16	22.77	6.27	2.97	3.08	0.99	2.09	4.62	0.66
epididymis, adult	10197-103E8	64.26	6.91	4.60	5.02	1.26	1.47	2.30	1.05	0.42	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.37	9.58	16.14	1.60	0.18	3.90	1.60	0.53	3.37	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.52	7.08	7.86	1.18	0.79	1.97	0.39	0.00	1.97	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	64.48	11.79	22.15	17.69	1.97	5.50	2.49	2.23	3.67	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	56.59	12.89	26.57	18.60	2.26	7.87	3.25	2.66	2.66	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	63.97	14.34	26.10	15.91	1.34	6.61	3.58	3.02	2.46	0.34
esophagus, adult, pool1	10015-101C6	75.70	8.60	10.83	7.43	2.02	3.72	2.12	2.44	2.12	1.59
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	42.08	9.39	13.15	7.89	0.13	2.00	1.50	1.13	1.13	0.38
eye - muscle inferior rectus, donor1	10272-104E2	21.73	4.83	2.41	16.90	0.00	0.00	4.83	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	4.21	4.21	6.31	0.00	2.10	0.00	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	16.37	1.49	2.98	19.35	1.49	1.49	1.49	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	26.37	6.88	2.29	10.32	1.15	1.15	2.29	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	7.29	2.91	1.46	7.29	2.91	0.00	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	52.12	6.86	2.80	24.15	1.27	4.07	2.54	5.08	0.25	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	51.03	9.62	7.69	2.82	2.31	1.67	0.38	0.13	1.15	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	101.38	10.92	11.40	7.36	3.09	4.75	1.66	0.95	1.90	1.66
frontal lobe, adult, pool1	10040-101F4	93.73	20.17	4.32	12.57	0.84	6.57	4.41	2.16	0.38	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	131.81	26.72	35.73	27.02	8.71	9.31	7.51	12.31	7.21	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	40.60	3.29	4.11	4.39	0.37	1.74	0.37	0.64	0.46	0.09
gall bladder, adult	10198-103E9	71.22	8.93	12.31	7.00	3.14	2.41	4.35	3.38	1.45	1.45
gamma delta positive T cells, donor1	11937-126A2	7.52	43.49	1.07	3.22	123.48	10.20	4.83	2.15	2.68	30.60
gamma delta positive T cells, donor2	11938-126A3	11.95	30.25	1.49	4.48	93.75	15.69	4.86	5.98	0.75	14.19
gastric adenocarcinoma cell line:MKN1	10614-108G2	45.41	4.65	17.74	7.60	0.84	2.75	1.90	2.32	4.65	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	50.87	12.57	20.50	3.87	1.35	4.26	1.74	0.58	6.58	1.16
gastric cancer cell line:AZ521	10549-107H9	39.35	13.94	9.84	4.10	0.98	2.95	1.64	0.49	1.80	0.98
gastric cancer cell line:GSS	10560-108A2	44.85	4.58	1.83	5.49	3.66	1.83	0.92	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	28.33	5.03	4.34	5.48	1.14	1.83	0.91	0.91	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	27.19	4.25	9.41	5.28	1.03	0.69	0.80	1.15	0.92	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	43.81	6.16	4.06	2.80	0.42	1.96	0.42	0.42	0.56	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	51.63	9.73	27.93	17.71	1.25	4.99	4.49	4.49	4.99	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	80.54	9.39	10.34	3.27	1.16	1.69	2.11	0.42	2.53	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	73.31	12.08	12.36	2.53	2.39	0.28	0.56	0.56	2.81	1.54
glioblastoma cell line:T98G	10485-107A8	77.81	9.71	12.14	3.97	2.76	3.31	1.10	1.21	2.43	0.88
glioma cell line:GI-1	10413-106B8	57.70	4.98	9.96	2.05	1.46	1.17	0.29	1.17	1.76	0.29
globus pallidus - adult, donor10196	10175-103C4	38.63	18.95	0.73	9.48	2.19	6.56	3.64	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	62.24	18.06	1.95	28.31	2.20	8.06	4.88	8.06	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	60.25	15.06	4.11	17.80	0.00	4.11	9.58	4.11	2.74	2.74
globus pallidus, newborn, donor10223	10364-105F4	53.82	8.53	3.20	5.33	3.20	3.73	0.53	0.53	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	7.34	36.71	0.00	7.34	0.00	4.89	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	43.71	0.00	0.00	10.93	0.00	10.93	0.00	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00	5.23	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	30.40	5.76	5.12	3.20	0.32	1.60	0.32	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	43.16	11.94	12.86	22.50	0.00	5.05	0.92	1.38	2.30	1.38
hIPS +CCl2, biol_rep2	14384-156C1	37.04	14.63	18.29	27.44	0.46	6.40	2.74	4.57	1.83	0.00
hIPS +CCl2, biol_rep3	14385-156C2	39.93	9.66	18.68	35.43	0.64	5.15	3.86	4.51	1.29	0.64
hIPS, biol_rep1	14380-156B6	30.18	5.75	4.31	23.00	1.44	10.06	5.75	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	41.15	6.17	12.35	17.83	0.00	5.49	5.49	1.37	3.43	0.00
hIPS, biol_rep3	14382-156B8	50.76	14.35	5.52	15.45	0.00	8.83	5.52	1.10	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	33.04	11.49	0.86	2.01	15.52	4.31	1.44	0.29	0.00	3.74
heart - mitral valve, adult	10205-103F7	30.79	4.78	2.69	7.18	0.60	3.89	1.49	1.79	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	39.74	3.14	2.61	12.81	0.26	2.88	2.35	2.09	0.52	0.52
heart - tricuspid valve, adult	10207-103F9	29.98	3.33	3.33	9.16	3.33	0.83	0.83	1.67	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	57.14	9.39	6.94	12.86	2.45	3.06	2.45	2.86	1.02	0.82
heart, adult, diseased, donor1	10051-101G6	47.27	5.96	3.83	17.88	0.85	3.41	2.98	1.28	0.00	0.85
heart, adult, pool1	10016-101C7	29.90	5.06	2.07	14.26	0.69	2.07	1.61	4.37	1.38	0.69
heart, fetal, pool1	10046-101G1	52.88	6.57	4.72	41.07	1.44	2.98	2.98	5.44	0.41	1.13
hepatic mesenchymal tumor cell line:LI90	10778-110G4	13.27	1.23	0.93	1.23	0.00	0.93	0.62	0.62	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	3.57	2.38	2.38	0.00	0.00	0.00	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.42	7.96	16.91	4.75	0.66	2.43	1.77	0.77	2.43	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	48.79	7.65	16.63	5.95	1.82	3.03	1.94	0.85	2.18	1.34
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	47.39	9.60	17.89	4.04	1.21	2.32	2.63	1.31	3.23	0.81
hepatoma cell line:Li-7	10484-107A7	27.80	7.23	6.45	9.34	2.22	4.00	1.67	1.22	0.89	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	39.50	15.68	5.93	4.62	16.98	5.03	1.51	0.80	0.50	4.22
hippocampus - adult, donor10196	10169-103B7	49.21	24.60	0.95	4.73	0.95	3.79	2.84	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	50.00	12.45	2.04	22.86	0.82	5.31	4.29	3.06	0.00	1.43
hippocampus, adult, donor10258	10374-105G5	58.26	15.44	2.99	6.97	0.50	8.96	3.98	0.50	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	46.88	7.75	3.88	3.17	2.82	3.52	2.47	0.70	1.41	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	63.48	12.82	22.58	39.67	0.61	6.10	4.88	9.16	2.44	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	56.35	7.66	16.10	21.01	1.37	3.53	1.18	4.71	1.96	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	47.48	10.41	17.01	24.88	0.76	4.06	2.29	4.82	2.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.78	3.95	6.20	27.63	1.13	5.64	2.82	2.82	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.06	8.26	4.91	35.89	0.77	2.84	1.81	4.13	1.81	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	41.00	5.69	7.97	31.51	0.38	4.56	2.28	1.90	1.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	53.14	7.30	9.93	14.89	0.29	3.21	4.67	1.46	0.58	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	46.75	6.46	4.52	17.88	1.29	3.66	1.51	3.02	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.29	6.26	9.18	12.10	1.25	2.50	3.34	0.83	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	40.25	11.84	6.63	14.44	0.95	3.55	1.66	1.89	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	44.36	11.57	4.34	12.05	1.13	4.18	2.57	2.41	0.48	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	47.80	10.77	8.08	13.47	0.67	6.06	4.04	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	66.98	15.80	20.81	21.75	2.66	4.69	1.41	5.16	3.60	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	56.01	19.65	28.00	30.95	3.93	5.90	2.95	2.95	3.44	2.46
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	98.62	16.58	31.42	20.07	7.85	5.24	6.98	4.36	1.75	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	43.15	11.26	8.02	35.51	0.19	3.63	2.10	4.96	1.72	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	37.07	14.39	10.03	35.76	0.44	3.49	2.62	2.62	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	41.48	14.49	9.50	44.98	1.50	7.00	2.50	6.00	0.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	46.16	8.67	5.46	28.45	0.94	1.88	0.38	3.58	1.70	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	49.56	13.64	8.18	29.10	2.27	2.27	0.91	1.36	2.27	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	58.26	9.08	5.95	19.73	1.57	1.57	0.94	1.88	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.17	8.33	5.39	15.84	1.63	3.10	1.47	1.63	0.33	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	46.74	13.93	4.94	11.61	3.19	2.61	1.45	1.45	0.87	3.19
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	53.21	10.16	5.68	12.85	1.79	2.69	1.49	2.99	1.49	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	61.52	13.12	17.92	22.35	2.22	4.62	2.22	3.88	2.03	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	62.76	13.69	14.83	23.96	2.28	3.42	3.14	3.71	3.14	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	73.90	17.15	28.99	32.26	3.27	6.53	2.86	3.67	4.08	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	47.18	13.38	10.56	25.70	0.70	3.52	2.82	3.17	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	40.54	11.72	8.24	19.95	1.58	1.58	2.22	1.58	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	55.38	8.17	12.10	24.21	0.30	3.93	3.03	2.42	2.42	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	55.33	14.48	6.72	12.93	2.07	2.07	1.03	2.07	0.00	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	51.80	9.30	3.32	11.29	1.33	2.66	0.66	1.99	1.33	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	45.15	5.90	5.90	8.47	1.80	2.31	1.28	3.08	0.26	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	46.27	12.02	7.41	8.44	1.28	4.09	1.79	1.28	0.26	1.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.92	8.33	7.57	11.36	0.76	6.06	0.76	1.51	1.51	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	60.15	13.44	8.74	5.71	2.02	2.35	1.34	1.01	2.35	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	64.48	13.52	15.70	25.12	2.66	5.31	2.42	3.62	3.14	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	69.97	10.25	18.72	19.16	2.23	5.79	4.46	7.58	3.12	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	60.98	19.51	20.98	21.46	2.44	6.34	1.46	4.88	2.44	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.31	12.53	4.89	33.01	0.31	3.67	2.44	2.75	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	39.04	13.01	13.01	224.47	0.00	9.76	0.00	9.76	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	54.61	9.60	9.60	42.69	0.33	2.65	2.98	3.97	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	64.03	13.68	4.38	21.34	1.09	3.83	2.19	1.09	3.83	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	58.99	12.30	6.51	11.58	0.36	5.43	2.17	1.45	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	55.16	11.03	5.34	13.17	0.71	2.85	1.07	2.14	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	53.70	9.55	5.97	9.55	0.00	1.19	2.39	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	63.11	14.63	7.45	15.98	1.49	2.84	1.35	1.63	1.08	2.57
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	50.11	7.27	4.58	5.66	2.42	2.69	0.81	1.89	1.08	1.62
immature langerhans cells, donor1	11904-125F5	12.59	9.69	6.78	1.70	3.15	1.70	0.73	0.97	1.70	0.48
immature langerhans cells, donor2	11905-125F6	25.35	4.75	8.71	2.38	6.34	3.17	0.79	0.00	0.79	0.00
insula, adult, pool1	10039-101F3	110.82	21.29	6.91	13.72	1.14	5.87	3.03	2.93	0.47	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	108.60	20.48	44.22	7.48	1.30	2.28	1.63	0.33	5.20	3.25
kidney, adult, pool1	10017-101C8	68.19	8.71	9.11	11.92	1.10	4.51	2.00	3.30	2.40	0.60
kidney, fetal, pool1	10045-101F9	75.40	11.95	9.41	18.82	1.06	4.74	3.68	4.60	0.21	1.06
large cell lung carcinoma cell line:IA-LM	10509-107D5	45.73	5.40	11.36	10.51	0.85	2.41	1.28	1.42	2.41	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	25.57	6.36	3.18	16.04	0.41	1.52	1.24	1.94	0.28	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	64.78	15.60	30.46	6.42	2.20	5.69	1.65	0.55	3.49	0.55
left atrium, adult, donor1	10079-102A7	35.96	5.45	3.27	7.08	1.09	0.00	0.54	3.27	0.54	0.54
left ventricle, adult, donor1	10078-102A6	44.50	3.54	4.05	5.56	0.00	0.51	1.52	2.02	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	24.35	6.84	6.84	3.83	0.55	1.64	1.37	0.27	2.19	0.00
leiomyoma cell line:10964C	10569-108B2	80.11	6.83	12.21	3.59	0.36	1.44	2.16	1.80	5.03	0.00
leiomyoma cell line:15242A	10570-108B3	53.80	3.80	16.85	2.17	0.00	2.17	1.09	0.54	2.17	0.00
leiomyoma cell line:15425	10571-108B4	69.45	3.16	7.28	2.91	0.73	1.21	0.73	1.46	2.91	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	39.73	9.41	3.14	6.27	0.00	5.23	3.14	2.09	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	70.72	7.56	18.30	4.49	8.15	2.36	1.30	1.42	6.97	1.30
liposarcoma cell line:KMLS-1	10782-110G8	57.95	8.44	7.97	3.91	0.94	2.66	1.41	0.78	1.56	0.62
liposarcoma cell line:SW 872	10726-110A6	38.74	8.53	3.53	5.00	1.34	1.83	1.46	0.61	1.22	0.37
liver, adult, pool1	10018-101C9	101.77	12.15	22.20	9.24	1.78	5.35	1.62	3.08	2.43	0.32
liver, fetal, pool1	10086-102B5	53.62	7.53	7.53	7.53	2.82	3.76	0.94	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	44.91	11.37	2.48	10.35	1.75	5.10	2.04	2.04	0.29	1.17
locus coeruleus, adult, donor10252	10165-103B3	48.35	11.81	1.11	20.30	2.21	2.95	2.58	6.64	0.00	1.29
locus coeruleus, adult, donor10258	10375-105G6	69.41	12.41	6.49	6.49	1.69	6.21	1.97	2.26	0.28	1.13
locus coeruleus, newborn, donor10223	10362-105F2	104.73	13.04	8.41	10.94	4.21	6.31	2.52	4.21	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	36.26	16.05	4.57	6.37	0.83	3.60	1.80	0.83	0.55	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	53.08	8.27	22.75	4.83	0.69	2.07	2.07	2.76	2.76	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	37.30	5.80	9.75	5.93	0.26	1.85	1.32	1.98	1.98	0.26
lung, adult, pool1	10019-101D1	38.86	9.92	5.67	9.10	3.31	3.31	2.13	2.72	0.24	1.54
lung, fetal, donor1	10068-101I5	109.60	13.41	8.28	21.12	3.14	5.99	4.00	3.42	0.29	1.14
lung, right lower lobe, adult, donor1	10075-102A3	70.57	12.37	4.12	4.58	5.50	1.37	2.29	1.37	0.46	1.83
lymph node, adult, donor1	10077-102A5	29.82	17.04	2.37	1.89	13.25	0.95	0.47	1.89	0.95	2.84
lymphangiectasia cell line:DS-1	10727-110A7	16.22	23.45	1.75	9.86	21.92	3.95	0.88	1.75	0.00	5.70
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	5.28	10.26	0.30	2.72	10.56	1.21	1.06	0.30	0.30	4.68
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	35.68	4.25	16.14	5.95	1.70	2.55	3.40	0.00	5.10	0.00
mature adipocyte, donor1	12231-129F8	31.52	4.00	1.78	6.66	0.89	3.11	1.78	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	34.86	7.68	1.87	2.91	0.42	4.98	1.66	0.21	0.21	0.42
mature adipocyte, donor3	12233-129G1	55.00	6.87	1.42	3.32	0.71	3.32	0.71	0.95	0.71	0.47
mature adipocyte, donor4	12234-129G2	45.01	5.26	1.84	4.21	0.53	2.90	2.11	0.53	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	70.05	16.44	9.29	13.82	3.34	2.38	0.71	0.71	0.95	2.14
medial frontal gyrus - adult, donor10196	10170-103B8	67.68	15.79	3.38	1.13	0.00	5.64	3.38	1.13	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	54.80	15.26	1.84	18.94	0.74	5.33	4.97	3.31	0.18	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	74.02	20.33	5.40	6.04	0.00	6.04	2.86	0.32	0.64	2.22
medial frontal gyrus, newborn, donor10223	10352-105E1	57.15	8.53	5.54	7.68	3.41	5.97	4.26	1.28	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	97.37	16.37	8.10	11.81	1.18	6.92	3.38	2.36	0.84	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	52.00	12.73	1.06	19.10	0.64	5.94	4.46	6.58	0.64	1.06
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	15.41	1.93	1.93	1.93	13.48	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	14.35	14.35	14.35	0.00	14.35	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	81.12	8.97	6.10	1.44	3.59	5.74	3.23	0.72	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	49.32	14.93	0.65	11.03	1.30	3.89	1.95	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	43.96	12.38	1.70	18.11	2.01	6.66	3.10	6.04	0.00	0.93
medulla oblongata, adult, pool1	10038-101F2	63.59	17.22	3.51	12.65	0.98	6.53	3.02	3.27	0.16	1.88
medulla oblongata, newborn, donor10223	10361-105F1	52.77	7.99	3.82	7.99	3.12	5.55	3.12	2.78	0.35	0.69
medulloblastoma cell line:D283 Med	10838-111E1	29.00	3.32	3.32	6.86	0.44	1.33	1.77	0.66	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	12.59	3.18	2.93	3.06	0.73	0.86	0.37	0.61	0.61	0.12
melanoma cell line:COLO 679	10514-107E1	52.04	10.49	14.95	1.29	3.02	3.59	1.01	0.86	2.16	0.43
melanoma cell line:G-361	10465-106H6	39.09	5.70	2.44	4.07	1.09	2.44	0.81	0.27	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	26.77	3.08	3.44	6.87	0.00	1.81	0.54	1.09	0.00	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	73.14	18.50	44.94	29.08	0.88	1.76	0.88	0.88	5.29	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	57.55	10.63	9.85	31.37	0.78	3.37	1.04	5.96	1.04	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	41.58	7.21	4.14	4.14	0.92	1.69	0.61	0.92	0.61	1.53
mesenchymal precursor cell - adipose, donor2	11748-123G2	29.45	4.00	2.54	2.54	0.18	1.64	0.36	0.36	0.00	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	64.60	7.87	4.56	2.48	0.41	1.66	1.66	0.83	1.24	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	33.15	2.25	3.23	2.95	0.28	1.40	0.98	0.70	0.14	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.25	3.08	5.58	2.70	0.39	1.16	0.19	0.39	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	54.14	3.47	3.47	2.08	0.00	2.08	1.39	0.00	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.75	5.84	5.49	7.90	0.69	1.89	0.51	1.54	0.34	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	36.46	4.03	3.45	3.80	0.46	1.27	0.58	1.04	0.46	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	44.17	5.44	7.03	2.52	0.13	1.59	0.93	0.27	1.19	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	43.48	4.59	7.43	8.37	0.81	2.16	0.81	1.49	1.35	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	24.90	3.27	6.69	3.84	0.57	1.56	0.85	0.43	1.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	27.67	6.92	1.65	2.96	0.66	3.95	0.33	0.66	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	32.52	4.84	6.37	2.49	0.55	1.11	0.97	0.14	0.97	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	57.25	2.79	7.33	1.40	0.70	1.75	0.70	1.40	0.70	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	31.65	3.27	3.47	2.25	0.41	1.02	0.00	0.61	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	28.76	2.16	3.95	3.24	1.08	1.44	1.44	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	40.86	2.69	4.86	3.31	0.21	1.55	0.72	0.62	0.31	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	39.44	2.74	8.66	0.91	0.68	1.60	0.68	0.46	4.10	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	65.87	4.20	15.10	4.20	0.42	2.94	0.00	1.26	5.87	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	28.09	3.89	3.74	2.54	0.30	0.45	0.60	0.90	0.60	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	41.31	3.94	7.79	2.28	0.88	1.05	0.53	0.53	1.05	0.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.92	5.15	2.95	3.31	0.74	2.21	1.10	0.74	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	24.90	2.58	3.43	1.43	0.29	0.00	0.00	0.57	2.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	36.63	2.11	4.63	3.37	0.84	1.26	0.84	2.95	1.68	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	43.38	6.39	3.20	0.91	0.91	0.46	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.30	2.30	5.63	1.28	0.00	1.79	1.28	1.53	0.26	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.17	2.88	6.54	1.31	0.52	2.36	1.31	0.26	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	41.28	3.08	3.39	1.23	0.31	0.92	1.54	0.31	2.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	39.54	2.59	7.30	2.35	0.94	1.41	0.71	0.00	0.71	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	44.00	4.74	7.45	1.02	0.00	2.03	0.00	0.68	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	37.73	5.89	5.89	1.18	0.79	2.36	0.79	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	39.39	2.78	5.56	1.39	0.00	0.93	0.46	0.93	0.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	53.36	3.46	5.48	1.15	0.29	1.44	0.29	0.00	1.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	42.17	3.79	6.02	0.89	0.22	1.56	0.89	0.45	0.89	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.91	3.36	6.73	2.16	1.44	2.16	0.72	0.00	1.20	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	34.47	6.60	9.53	0.00	0.73	0.00	0.00	0.73	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	38.26	3.69	4.70	2.35	0.67	1.34	0.00	0.00	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.98	2.05	5.32	1.64	0.41	2.46	1.23	0.82	2.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.25	4.30	3.01	0.00	0.43	3.01	1.29	0.00	0.86	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	5.47	5.47	0.00	2.73	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	0.00	5.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	31.18	3.57	4.22	1.30	0.97	0.97	0.32	0.00	1.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	34.92	1.45	7.27	0.00	0.00	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.12	3.20	4.26	1.07	0.53	0.00	0.00	0.00	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	25.35	2.45	7.36	0.82	0.82	2.45	0.82	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	28.77	1.55	4.28	0.78	0.00	1.55	1.17	0.00	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	29.38	6.30	6.30	2.10	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	28.81	3.97	4.97	0.00	0.00	1.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	0.00	4.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	33.80	4.15	4.74	1.19	0.00	2.37	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	34.12	2.44	7.31	1.22	0.00	2.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	32.30	1.90	4.43	0.63	0.63	1.27	3.17	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	31.04	2.76	4.14	0.34	0.34	1.72	0.00	0.00	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	42.98	6.45	4.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	51.89	3.99	7.98	0.00	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	58.55	3.44	6.89	3.44	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	58.27	4.48	5.70	0.81	0.81	0.81	0.41	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	49.26	2.38	2.38	0.79	0.79	2.38	0.00	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	57.77	3.54	2.95	0.59	0.59	2.36	1.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	43.02	1.87	2.49	1.56	0.62	1.25	0.94	0.31	0.00	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	38.76	1.34	4.01	0.00	2.67	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	62.68	2.37	7.10	0.00	1.18	3.55	1.18	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	2.57	5.14	2.57	0.00	2.57	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.14	5.51	4.82	2.75	0.00	2.75	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	49.48	6.93	2.47	5.44	0.00	3.46	1.48	1.98	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	44.86	6.73	1.12	2.24	1.12	1.12	3.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	48.98	6.36	2.54	6.36	0.00	3.82	1.91	0.00	1.91	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	51.98	6.85	3.63	3.63	0.81	4.03	3.22	1.21	1.21	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	6.54	4.36	2.18	0.00	6.54	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	62.09	8.87	1.27	5.07	1.27	5.07	1.27	2.53	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	6.07	1.82	3.03	0.00	3.03	1.21	1.21	0.61	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	22.59	4.52	0.00	0.00	13.56	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.13	13.18	2.47	1.65	0.00	7.41	2.47	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	44.05	4.37	1.39	2.78	0.60	2.18	0.60	0.60	0.79	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	43.16	2.60	1.30	1.62	0.97	2.60	1.30	0.32	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	37.69	4.07	3.06	3.06	1.02	1.02	0.00	1.02	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	3.87	2.32	0.00	1.55	3.09	0.00	1.55	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	50.32	11.58	5.67	3.54	0.71	2.36	0.94	0.47	1.18	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	63.94	8.57	33.36	2.09	9.50	2.09	1.39	1.85	24.33	1.16
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	59.83	8.55	42.74	0.00	0.00	0.00	0.00	0.00	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	74.70	8.53	15.21	3.80	1.85	5.75	2.36	1.64	3.90	0.31
mesothelioma cell line:Mero-25	10850-111F4	71.72	7.49	39.49	1.36	3.86	5.22	0.45	0.23	8.40	0.68
mesothelioma cell line:Mero-41	10851-111F5	34.23	5.62	4.16	1.22	0.73	1.22	1.22	0.24	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	58.46	4.87	20.59	3.10	2.21	1.55	1.55	0.89	5.76	0.89
mesothelioma cell line:Mero-82	10853-111F7	47.04	10.25	29.43	4.99	1.58	4.47	1.58	2.37	2.89	0.53
mesothelioma cell line:Mero-83	10854-111F8	53.96	7.49	15.32	2.55	0.51	2.72	0.51	1.36	3.74	0.51
mesothelioma cell line:Mero-84	10855-111F9	58.14	10.36	22.50	1.52	1.26	4.55	3.03	1.01	6.57	0.25
mesothelioma cell line:Mero-95	10856-111G1	60.87	8.28	23.60	2.48	1.45	2.28	1.24	0.83	6.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	52.34	7.12	10.77	3.31	1.66	1.49	1.49	0.17	3.15	0.83
mesothelioma cell line:NCI-H226	10846-111E9	54.30	5.25	15.02	2.17	1.63	1.99	1.09	0.18	5.43	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	89.85	10.76	11.96	3.25	1.54	3.25	2.22	0.51	4.10	0.17
mesothelioma cell line:NCI-H28	10845-111E8	47.59	7.38	8.91	5.85	0.51	3.05	2.80	2.54	0.76	0.00
mesothelioma cell line:No36	10857-111G2	55.13	13.37	7.83	2.28	1.96	6.52	1.96	1.63	1.63	0.98
mesothelioma cell line:ONE58	10858-111G3	22.76	1.90	1.90	0.54	0.81	1.35	0.54	0.27	0.54	0.27
migratory langerhans cells, donor1	11901-125F2	9.79	3.26	1.54	5.76	0.19	1.34	0.38	2.11	1.15	0.38
migratory langerhans cells, donor2	11902-125F3	6.84	2.56	0.61	6.72	0.98	1.59	0.37	1.10	0.12	0.61
migratory langerhans cells, donor3	11903-125F4	15.44	1.26	0.54	4.85	1.26	1.44	0.36	2.51	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	53.87	6.86	19.92	1.31	1.63	7.18	0.33	0.33	1.63	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	41.33	4.45	10.60	0.85	1.27	2.97	1.48	0.00	1.27	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.50	6.68	15.20	2.30	0.92	2.07	0.46	0.46	5.07	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.68	13.89	3.23	2.28	14.84	1.52	0.76	0.76	0.38	1.90
myelodysplastic syndrome cell line:SKM-1	10772-110F7	39.92	17.00	5.17	4.62	9.05	2.77	0.55	0.92	0.37	3.33
myeloma cell line:PCM6	10474-106I6	16.60	14.03	3.16	1.78	11.86	1.98	0.40	0.79	0.20	5.34
myxofibrosarcoma cell line:MFH-ino	10600-108E6	15.73	5.58	3.04	7.10	0.51	3.04	0.51	0.51	1.52	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	24.71	4.12	1.18	5.69	0.39	2.35	0.78	2.35	0.20	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	43.79	9.36	9.92	11.70	1.56	3.57	1.11	2.67	1.11	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	44.34	8.97	12.58	9.49	1.03	4.19	1.32	2.72	1.69	1.25
nasal epithelial cells, donor2	12227-129F4	30.36	10.49	11.04	4.97	0.55	1.10	0.00	0.00	2.21	0.55
neuroblastoma cell line:CHP-134	10508-107D4	39.80	12.19	2.30	29.68	0.23	4.14	2.76	2.30	0.23	0.69
neuroblastoma cell line:NB-1	10539-107G8	40.22	9.92	5.05	45.65	0.94	4.49	2.62	12.72	0.75	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	90.68	18.35	12.86	4.01	1.48	3.16	0.84	0.63	0.42	2.11
neuroblastoma cell line:NH-12	10555-107I6	19.19	7.83	0.93	15.28	0.00	2.61	0.93	1.49	0.56	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	48.39	6.88	8.54	4.51	0.00	2.14	0.47	1.42	0.47	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	59.08	11.72	19.64	3.01	0.48	3.64	1.58	0.32	1.74	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	52.13	12.88	9.26	11.47	1.21	2.82	1.61	2.42	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	24.16	8.90	4.45	2.54	0.00	4.45	0.64	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	32.21	4.26	5.06	0.53	0.27	1.86	0.53	0.27	0.53	0.00
neutrophil PMN, donor1	12133-128D9	0.00	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	13.28	0.00	0.00	13.28	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	9.47	66.29	0.00	0.00	0.00	9.47	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	7.78	32.30	0.17	18.60	16.74	5.41	3.21	3.04	0.00	5.07
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	104.07	8.01	15.21	44.03	4.00	3.20	0.00	12.81	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	53.86	6.41	4.49	1.92	1.60	0.96	0.96	0.64	0.96	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	32.32	3.68	4.47	2.36	0.00	2.10	1.58	0.53	0.00	0.79
nucleus accumbens, adult, pool1	10037-101F1	87.93	19.31	6.56	12.65	0.66	6.19	3.19	2.91	0.84	0.47
occipital cortex - adult, donor10196	10172-103C1	72.11	45.33	4.12	16.48	8.24	4.12	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	49.65	17.44	0.27	22.81	1.88	7.51	6.44	5.64	0.00	0.81
occipital cortex, newborn, donor10223	10355-105E4	79.34	6.91	5.10	2.18	1.09	5.10	5.10	1.09	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	92.89	21.78	5.25	11.55	1.84	7.35	4.46	1.84	0.00	2.10
occipital lobe, fetal, donor1	10073-102A1	64.79	18.45	0.86	2.57	0.86	1.29	3.00	0.86	0.00	1.72
occipital pole, adult, pool1	10036-101E9	89.49	22.47	3.86	15.37	0.79	6.62	4.18	2.29	0.63	1.02
olfactory region, adult	10195-103E6	69.35	15.09	4.78	10.13	0.57	5.35	2.87	1.53	0.76	0.76
optic nerve, donor1	10277-104E7	58.03	34.02	4.00	6.00	0.00	20.01	0.00	2.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	56.16	7.63	11.28	3.87	1.14	1.03	0.46	0.91	1.94	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	29.54	6.59	6.05	4.81	0.14	1.51	0.41	0.55	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	49.78	5.93	23.20	5.42	0.68	3.73	0.68	1.86	3.89	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	30.03	8.43	30.73	4.85	0.69	3.58	2.31	0.92	2.43	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	21.75	5.00	2.65	2.65	0.00	2.65	0.29	1.18	0.00	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	52.32	11.21	16.82	0.00	0.93	3.74	0.00	0.00	3.74	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	41.35	5.30	4.45	5.30	1.06	3.18	1.91	1.27	0.85	0.21
ovary, adult, pool1	10020-101D2	59.14	7.95	4.45	10.05	1.05	4.28	1.92	2.18	0.87	0.26
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	32.26	3.85	4.58	4.77	0.55	2.20	0.55	0.92	1.28	0.18
pancreas, adult, donor1	10049-101G4	53.62	10.35	11.29	21.63	0.94	2.82	2.82	9.41	0.94	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	42.21	5.87	17.89	2.52	1.12	2.24	1.96	0.56	2.52	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	54.85	7.67	11.92	2.73	1.53	2.90	1.19	0.85	2.56	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	14.07	2.32	7.78	4.80	0.33	1.16	0.17	0.83	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	83.83	20.59	3.75	12.90	0.09	5.86	4.30	2.47	0.55	0.64
parietal cortex, adult, donor10258	10373-105G4	49.91	17.62	5.87	11.01	0.73	4.40	2.20	0.73	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	58.31	15.05	3.76	15.05	0.94	7.52	2.82	1.88	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	54.16	13.40	1.71	15.68	1.43	5.70	3.99	3.42	0.29	0.57
parietal lobe, adult, pool1	10034-101E7	89.71	22.73	3.88	14.98	0.70	7.67	3.61	2.82	0.18	1.94
parietal lobe, fetal, donor1	10072-101I9	77.59	21.34	0.00	5.82	2.91	0.97	1.94	0.00	0.00	1.94
parietal lobe, newborn, donor10223	10356-105E5	76.64	7.48	6.73	4.11	3.36	4.49	2.99	1.50	1.87	0.37
parotid gland, adult	10199-103F1	93.12	6.17	11.10	14.80	0.62	1.85	1.23	4.93	1.23	0.00
penis, adult	10200-103F2	67.68	4.30	4.83	8.59	1.61	0.54	1.61	1.61	2.69	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	56.90	4.28	14.87	2.23	0.93	1.49	0.74	0.00	0.56	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	81.44	20.83	16.75	5.39	1.89	3.64	2.48	1.17	4.23	0.73
pineal gland - adult, donor10196	10179-103C8	33.54	16.13	2.58	34.19	0.65	1.94	1.29	1.94	0.65	1.94
pineal gland, adult, donor10252	10160-103A7	41.45	8.29	0.59	73.43	0.59	1.78	2.37	13.03	0.00	1.18
pineal gland, adult, donor10258	10377-105G8	54.56	5.64	1.25	26.34	0.63	1.25	0.63	4.39	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	58.68	8.09	3.04	31.37	0.00	2.02	1.01	2.02	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	70.36	13.55	2.08	49.51	0.52	4.17	3.65	7.82	0.52	3.65
pituitary gland, adult, donor10258	10378-105G9	85.98	8.51	7.66	21.28	0.85	5.96	2.55	1.70	0.00	1.70
placenta, adult, pool1	10021-101D3	65.15	15.91	8.82	9.57	2.37	4.41	2.04	1.51	1.72	1.94
plasma cell leukemia cell line:ARH-77	10840-111E3	8.48	11.52	1.19	1.19	11.52	2.25	0.53	0.13	0.00	2.12
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	19.45	2.80	2.96	4.82	0.93	0.78	0.31	1.56	0.62	0.47
pons, adult, pool1	10033-101E6	61.97	19.45	3.01	12.91	1.29	5.08	3.79	3.70	0.34	1.38
postcentral gyrus, adult, pool1	10032-101E5	100.69	21.97	3.92	12.03	0.61	6.28	3.57	2.88	0.44	1.57
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	12.55	0.00	0.00	0.00	6.27	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	27.54	11.02	0.00	5.51	11.02	11.02	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	104.44	17.48	21.56	7.14	1.02	4.22	3.06	0.73	4.66	0.73
prostate cancer cell line:PC-3	10439-106E7	62.26	6.17	11.80	8.71	2.54	1.45	1.63	2.18	2.54	0.73
prostate, adult, pool1	10022-101D4	64.30	8.53	6.53	15.87	1.27	5.44	2.99	4.26	0.36	1.09
putamen, adult, donor10196	10176-103C5	66.81	14.87	4.25	13.69	0.71	5.67	3.30	2.12	0.24	0.71
putamen, adult, donor10252	10152-102I8	41.18	7.84	1.96	11.76	0.00	3.92	3.92	7.84	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	39.34	6.56	7.65	14.21	0.00	6.56	4.37	1.09	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	53.64	14.74	3.87	7.73	0.24	5.56	3.62	1.21	0.48	0.24
putamen, newborn, donor10223	10365-105F5	88.46	14.99	6.75	17.24	7.50	7.50	2.25	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	31.42	7.86	30.84	2.33	2.04	0.87	0.29	0.58	5.53	0.29
rectum, fetal, donor1	10067-101I4	43.12	9.74	2.78	4.17	4.17	4.17	2.78	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.46	6.57	5.30	3.18	1.70	2.33	1.06	0.64	1.06	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	0.83	2.49	4.97	0.41	0.41	0.41	0.00	0.41	0.00
retina, adult, pool1	10030-101E3	64.21	15.51	3.68	22.07	2.09	4.87	3.08	4.08	0.60	1.09
retinoblastoma cell line:Y79	10475-106I7	33.25	6.75	11.17	21.56	1.56	3.12	1.56	2.08	1.04	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	36.15	5.53	32.34	2.34	0.49	2.46	0.49	0.25	8.73	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	39.09	9.00	6.75	5.62	0.56	0.84	0.56	0.84	2.25	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	3.79	0.76	0.76	0.76	0.76	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	42.73	4.37	11.33	3.40	1.46	1.29	0.65	0.32	0.49	0.81
salivary acinar cells, donor2	11772-123I8	51.91	5.92	12.67	3.03	1.51	2.07	0.69	0.83	0.96	0.55
salivary acinar cells, donor3	11773-123I9	47.01	5.96	19.86	0.66	0.66	2.65	0.66	0.66	1.32	0.66
salivary gland, adult, pool1	10093-102C3	102.38	11.44	8.58	22.88	0.00	5.15	0.57	2.29	1.14	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.21	11.30	6.15	1.10	1.43	1.94	1.69	0.17	0.34	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	52.90	13.64	5.88	1.18	1.29	2.35	1.18	0.24	0.59	1.06
seminal vesicle, adult	10201-103F3	89.94	6.88	9.52	7.94	1.59	2.65	2.12	2.65	2.65	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	27.69	5.83	11.90	2.19	0.49	1.94	2.43	3.16	3.40	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	7.30	3.27	1.76	2.26	0.50	0.50	0.00	1.51	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	22.08	2.01	8.03	1.00	0.00	1.00	1.00	0.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	31.70	5.10	25.79	6.85	0.67	0.81	1.21	2.55	3.63	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	51.28	10.06	18.24	5.19	0.88	4.20	1.77	1.44	2.21	0.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	39.35	4.77	30.32	10.58	0.39	2.19	1.81	2.19	4.00	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	34.76	4.97	7.09	11.35	0.71	0.71	1.42	2.84	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	54.45	5.16	13.07	15.11	0.60	3.24	1.56	3.12	0.96	0.24
skeletal muscle, fetal, donor1	10066-101I3	41.21	10.05	2.01	8.04	2.01	1.01	0.00	1.01	1.01	1.01
skin, adult, donor1	10074-102A2	94.99	6.79	27.14	13.57	0.00	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	61.23	10.73	5.05	5.68	1.89	1.89	2.52	3.79	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	67.37	21.01	10.67	5.67	1.33	3.67	2.67	2.33	2.00	3.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	42.55	7.88	7.56	32.15	1.26	2.84	0.63	3.78	0.63	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	79.03	13.69	4.63	3.47	0.77	4.24	2.89	0.39	0.00	0.77
small cell lung carcinoma cell line:LK-2	10541-107H1	66.26	9.07	12.36	6.76	1.15	2.64	1.32	0.33	1.48	1.15
small cell lung carcinoma cell line:NCI-H82	10842-111E5	20.11	4.66	1.45	60.80	0.64	1.93	1.45	2.09	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	38.14	16.13	6.76	10.24	1.53	3.70	3.05	2.18	1.53	0.65
small intestine, adult, pool1	10024-101D6	71.79	18.75	12.66	21.14	8.12	7.88	2.15	7.17	1.07	4.54
small intestine, fetal, donor1	10064-101I1	51.60	9.34	12.28	8.11	2.70	2.21	1.72	1.47	0.25	1.72
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	47.19	4.62	23.08	5.64	3.59	2.05	3.08	0.51	5.13	0.51
smooth muscle, adult, pool1	10048-101G3	62.29	8.79	3.62	5.69	2.07	1.29	1.81	2.58	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	40.74	14.21	7.77	6.70	3.75	0.80	1.88	2.41	2.68	2.41
spinal cord - adult, donor10196	10181-103D1	65.38	17.89	1.15	7.34	2.06	4.82	2.29	0.92	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	52.83	19.71	0.00	18.92	4.73	5.91	3.15	3.94	0.00	1.18
spinal cord, adult, donor10258	10369-105F9	60.88	24.90	1.38	15.91	2.08	9.69	4.84	1.38	0.69	2.08
spinal cord, fetal, donor1	10056-101H2	66.47	15.86	1.22	21.95	1.22	6.10	4.88	3.05	0.00	1.83
spinal cord, newborn, donor10223	10359-105E8	75.77	17.45	3.67	14.69	1.84	4.13	1.38	2.76	0.92	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	14.94	2.69	2.39	2.54	0.60	0.15	0.60	0.45	0.30	0.60
spleen, adult, pool1	10025-101D7	23.90	17.73	0.99	4.41	10.79	4.30	2.42	1.43	0.22	3.63
spleen, fetal, pool1	10044-101F8	30.03	15.57	2.46	9.46	7.71	5.24	2.70	2.62	0.16	3.73
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	20.91	8.80	1.04	4.45	5.80	2.48	1.35	1.04	0.41	2.90
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	71.77	11.01	12.34	12.72	1.52	2.85	1.71	3.04	0.76	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	83.52	12.23	12.58	18.17	2.45	4.19	1.40	1.40	1.75	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	26.97	4.30	22.28	1.17	1.17	2.74	0.39	0.00	5.86	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	63.26	20.71	30.50	15.76	3.15	4.16	2.93	4.39	3.15	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	67.35	5.93	19.49	9.74	0.42	3.39	1.69	1.27	2.12	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	43.15	6.77	20.73	2.96	1.69	2.12	1.27	0.42	6.35	0.00
stomach, fetal, donor1	10062-101H8	36.31	16.02	11.75	4.27	2.14	1.07	2.14	2.14	2.14	3.20
submaxillary gland, adult	10202-103F4	66.65	10.82	3.99	13.10	6.27	1.71	2.28	3.42	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	53.38	10.80	1.25	28.66	2.08	7.27	5.19	9.76	0.00	1.25
substantia nigra, adult, donor10258	10371-105G2	41.38	16.55	1.55	10.86	0.52	8.28	2.59	1.55	0.00	2.07
substantia nigra, newborn, donor10223	10358-105E7	69.24	4.95	4.24	4.24	2.83	7.77	3.53	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	34.85	4.81	7.11	2.98	0.23	1.15	1.15	0.46	1.38	0.23
temporal lobe, adult, pool1	10031-101E4	111.81	24.84	4.75	11.61	0.68	8.22	3.48	3.90	0.68	1.27
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	52.71	20.66	1.42	9.26	0.71	4.27	2.14	1.42	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	57.14	13.19	0.88	5.71	0.44	7.91	2.64	1.76	0.44	0.88
tenocyte, donor1	11763-123H8	37.70	4.89	2.79	3.49	0.35	4.89	0.70	1.40	0.00	1.05
tenocyte, donor2	11765-123I1	35.86	7.25	1.53	2.29	0.00	1.53	0.76	0.38	0.76	0.38
tenocyte, donor3	11768-123I4	39.66	5.93	4.08	1.48	0.37	1.11	1.48	0.74	0.74	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	71.55	5.27	17.51	30.76	0.85	2.55	1.02	5.61	2.89	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	53.49	11.87	12.33	12.49	0.92	3.24	2.93	3.85	0.62	1.54
teratocarcinoma cell line:PA-1	10807-111A6	30.69	9.92	11.47	23.71	0.93	3.41	1.24	2.32	1.08	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	63.60	8.89	23.61	22.72	1.40	5.46	3.30	8.12	3.30	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	43.87	5.29	13.61	9.45	0.38	2.27	0.76	0.76	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	44.72	3.93	53.44	13.31	0.76	2.07	0.22	3.16	2.94	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	71.98	11.07	36.15	2.93	0.98	1.63	0.65	0.00	3.26	0.33
testis, adult, pool1	10026-101D8	63.35	20.83	4.83	37.26	1.29	7.09	3.65	3.01	1.50	1.61
testis, adult, pool2	10096-102C6	63.15	29.77	2.26	42.40	1.80	8.12	4.96	2.26	0.45	2.26
thalamus - adult, donor10196	10168-103B6	71.76	24.29	4.42	13.25	5.52	7.73	6.62	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	50.79	11.88	0.94	21.41	1.56	7.50	5.47	7.81	0.16	1.25
thalamus, adult, donor10258, tech_rep1	10370-105G1	69.28	12.32	0.00	13.86	1.54	9.24	4.62	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	57.31	12.68	3.62	4.61	1.48	3.79	2.14	2.64	0.49	0.49
thalamus, newborn, donor10223	10366-105F6	94.93	6.33	6.90	5.18	2.30	4.03	1.73	1.73	1.15	1.15
throat, adult	10209-103G2	49.68	8.99	8.24	9.24	2.25	2.00	3.50	2.00	0.25	0.25
throat, fetal, donor1	10061-101H7	37.78	12.80	2.74	7.01	2.13	3.05	0.30	1.22	0.61	2.74
thymic carcinoma cell line:Ty-82	10803-111A2	21.46	2.38	5.56	1.19	0.00	0.79	0.79	0.00	0.20	0.40
thymus, adult, pool1	10027-101D9	34.89	46.82	3.58	8.15	15.51	12.03	5.96	3.58	0.50	8.95
thymus, fetal, pool1	10043-101F7	38.96	50.19	3.12	10.70	17.98	12.57	4.16	3.01	0.94	9.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	26.73	2.93	9.17	2.79	1.60	1.06	1.33	1.06	2.66	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	103.65	19.28	30.03	7.82	3.07	5.03	1.68	1.96	3.63	1.12
thyroid, adult, pool1	10028-101E1	91.45	12.41	6.25	27.25	0.75	5.97	3.92	5.32	0.47	0.93
thyroid, fetal, donor1	10060-101H6	70.13	12.39	2.37	12.66	2.11	2.64	3.95	2.37	0.26	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	27.72	3.08	9.24	0.00	0.00	0.00	0.00	6.16	0.00	0.00
tongue, adult	10203-103F5	64.42	6.98	12.09	8.84	1.86	2.09	1.63	2.09	1.16	0.93
tongue, fetal, donor1	10059-101H5	40.59	4.73	2.76	22.07	0.39	3.55	0.39	3.55	0.00	0.00
tonsil, adult, pool1	10047-101G2	41.87	24.14	7.91	7.11	15.13	5.81	2.40	2.91	1.70	5.61
trachea, adult, pool1	10029-101E2	37.63	9.98	5.73	12.19	1.80	3.44	1.64	2.78	0.57	0.98
trachea, fetal, donor1	10058-101H4	48.86	11.54	4.23	8.85	1.15	3.08	0.77	1.92	1.54	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	40.74	3.19	10.63	2.13	0.00	1.77	0.71	1.06	2.13	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	26.85	5.07	14.89	8.71	1.11	2.84	1.42	1.11	2.23	0.61
transitional-cell carcinoma cell line:JMSU1	10492-107B6	31.18	8.93	11.59	0.78	1.10	1.25	1.10	0.16	0.78	0.16
tridermal teratoma cell line:HGRT	10694-109G1	13.32	0.00	7.61	1.90	0.00	0.00	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.19	6.35	6.09	5.50	0.59	1.78	0.59	1.02	0.68	0.25
umbilical cord, fetal, donor1	10057-101H3	58.42	4.17	10.43	4.17	0.00	4.17	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	90.60	15.36	7.00	9.90	2.22	5.29	2.90	2.39	0.85	1.54
uterus, fetal, donor1	10055-101H1	41.98	9.73	2.56	4.10	1.54	3.07	2.05	2.56	0.51	0.51
vagina, adult	10204-103F6	36.83	10.34	1.94	15.51	5.17	9.05	3.23	4.52	0.00	1.94
vein, adult	10191-103E2	41.43	21.26	3.29	3.51	10.30	4.38	4.38	2.19	0.22	3.73
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.31	12.28	3.47	2.67	8.55	2.67	1.07	0.53	0.80	2.40